<SEC-DOCUMENT>0001193125-22-212555.txt : 20220804
<SEC-HEADER>0001193125-22-212555.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220804162336
ACCESSION NUMBER:		0001193125-22-212555
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804
EFFECTIVENESS DATE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			II-VI INC
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266529
		FILM NUMBER:		221136988

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d388182ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
<HTML><HEAD>
<TITLE>S-3ASR</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on August 4, 2022 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;S-3</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI&nbsp;Incorporated</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Pennsylvania</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">25-1214948</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>375 Saxonburg Boulevard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Saxonburg, Pennsylvania 16056 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Ronald Basso </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Chief Legal
and Compliance Officer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>375 Saxonburg Boulevard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Saxonburg, Pennsylvania 16056 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Andrew J. Nussbaum, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Karessa L. Cain, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Wachtell, Lipton, Rosen&nbsp;&amp; Katz</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>51 West 52<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP>&nbsp;Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10019</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: <FONT STYLE="white-space:nowrap">(212)&nbsp;403-1000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>D. Mark McMillan</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Jeffrey W. Acre</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>K&amp;L
Gates</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>70 West Madison Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Chicago, Illinois 60602</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (312) <FONT STYLE="white-space:nowrap">372-1121</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public: </B>From time to time after the effective date of this Registration Statement as determined
by market conditions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment
plans, please check the following box.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following
box.&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D.
filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
<FONT STYLE="white-space:nowrap">a&nbsp;non-accelerated&nbsp;filer,</FONT> a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting
company,&#148; and &#147;emerging growth company&#148; <FONT STYLE="white-space:nowrap">in&nbsp;Rule&nbsp;12b-2&nbsp;of</FONT> the Exchange Act. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;Reporting&nbsp;Company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;Growth&nbsp;Company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g388182g82q21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
relates to the offer and sale from time to time by the selling securityholders named herein or such selling securityholders as may be named in one or more prospectus supplements, of (i)&nbsp;up to 140,000 shares of our
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, no par value per share <FONT STYLE="white-space:nowrap">(&#147;Series&nbsp;B-2</FONT> Convertible Preferred Stock&#148;), and (ii)&nbsp;shares of our common stock,
no par value per share (&#147;Common Stock&#148;), issuable upon conversion of the shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, including pursuant to an increased stated value as a result of accrued <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dividends&nbsp;payable-in-kind&nbsp;on</FONT></FONT> the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the closing date of the Coherent Merger (as defined below), BCPE Watson (DE) BML, LP, a Delaware limited partnership (&#147;BML&#148;),
became the beneficial owner of 75,000 newly issued shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and BCPE Watson (DE) ORML, LP, a Delaware limited partnership (&#147;ORML,&#148; and together with BML,
the &#147;Holders&#148;) became the beneficial owner of 65,000 newly issued shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. The selling securityholders may offer and sell shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and/or shares of Common Stock that may be issued upon conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock in amounts, at
prices and on terms that will be determined at the time of the offering. We will not receive any proceeds from the sale of any shares of Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock by the
selling securityholders, but we have agreed to pay certain registration expenses, other than underwriting discounts and commissions, applicable transfer taxes, and the fees and expenses of any auditor or those of more than one legal counsel engaged
by the selling securityholders, in connection with offerings by the selling securityholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the resale of shares of
Common Stock and <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock pursuant to the terms of the Registration Rights Agreement described under &#147;Description of Capital Stock,&#148; but the registration of such
shares does not necessarily mean that any of such shares will be offered or sold by the selling securityholders pursuant to this prospectus or at all. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus describes the general manner in which the shares of Common Stock and <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock may be offered and sold by the selling securityholders. Any prospectus supplement may add, update, or change information contained in this prospectus. You should carefully read this prospectus and any applicable
prospectus supplement, as well as the documents incorporated by reference herein or therein, before you invest in the Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Common Stock is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148; The
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is not listed on an exchange and we do not intend to list the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock on any exchange.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE &#147;RISK&nbsp;FACTORS&#148; BEGINNING ON PAGE 7 OF THIS PROSPECTUS, AS WELL AS THE RISK
FACTORS DESCRIBED UNDER THE HEADING &#147;<A HREF="#rom388182_5">RISK&nbsp;FACTORS</A>&#148; IN OUR MOST RECENT ANNUAL REPORT ON <FONT STYLE="white-space:nowrap">FORM&nbsp;10-K</FONT> AND EACH SUBSEQUENT QUARTERLY REPORT ON <FONT
STYLE="white-space:nowrap">FORM&nbsp;10-Q</FONT> (WHICH DOCUMENTS ARE INCORPORATED BY REFERENCE HEREIN), BEFORE YOU INVEST IN SHARES OF COMMON STOCK OR <FONT STYLE="white-space:nowrap">SERIES&nbsp;B-2</FONT> CONVERTIBLE PREFERRED STOCK. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission (&#147;SEC&#148;) nor any state securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is August 4, 2022. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_2">SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_3">TRADEMARKS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_4">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_7">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_9">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_10">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom388182_14">INCORPORATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an &#147;automatic shelf&#148; registration statement that we filed with the SEC as a &#147;well-known seasoned
issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). By using a shelf registration statement, the selling securityholders may sell the Common Stock or
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock from time to time and in one or more offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
prospectus provides you with a general description of the Common Stock and <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock that the selling securityholders may offer. Each time a selling securityholder sells
shares of Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock using this prospectus, to the extent necessary, we will provide a prospectus supplement that will contain specific information about the
terms of that offering, the number of shares being offered, the manner of distribution, the identity of any underwriters or other counterparties and other specific terms related to the offering. The prospectus supplement may also add, update or
change information contained or incorporated by reference in this prospectus. If there is any inconsistency between the information in this prospectus and any prospectus supplement, you should rely on the information provided in the prospectus
supplement. This prospectus does not contain all of the information included in the registration statement of which the prospectus forms a part. The registration statement filed with the SEC includes or incorporates by reference exhibits that
provide more details about the matters discussed in this prospectus. You should carefully read the entirety of this prospectus, the related exhibits filed with the SEC and any applicable prospectus supplement, together with the additional
information described below under the headings &#147;Where You Can Find More Information&#148; and &#147;Incorporation by Reference&#148; before making an investment decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When acquiring any securities in an offering pursuant to this prospectus, you should rely on the information provided in this prospectus and
any applicable prospectus supplement, including the information incorporated by reference. Neither we, nor any underwriters or agents, have authorized anyone to provide you with different information. The selling securityholders are not offering
securities in any state where such an offer is prohibited. You should not assume that the information in this prospectus, any prospectus supplement, or any document incorporated by reference, is truthful or complete at any date other than the date
mentioned on the cover page of those documents. You should also carefully review the section entitled &#147;Risk Factors,&#148; which highlights certain risks associated with an investment in our securities, to determine whether an investment in the
Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is appropriate for you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the
context otherwise requires, references in this prospectus <FONT STYLE="white-space:nowrap">to&nbsp;&#147;II-VI,&#148;&nbsp;the</FONT> &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; are
<FONT STYLE="white-space:nowrap">to&nbsp;II-VI&nbsp;Incorporated</FONT> and its subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_2"></A>SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the statements contained or incorporated by reference into this prospectus are &#147;forward-looking statements&#148; within the
meaning of the Private Securities Litigation Reform Act of 1995. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Words such as &#147;anticipate,&#148; &#147;estimate,&#148;
&#147;continue,&#148; &#147;expect,&#148; &#147;project,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;believe,&#148; &#147;target,&#148; &#147;objective,&#148; &#147;goal,&#148; &#147;positions,&#148; &#147;prospects,&#148;
&#147;potential,&#148; &#147;will,&#148; &#147;would,&#148; &#147;should,&#148; &#147;could,&#148; &#147;may&#148; and words and terms of similar substance identify forward-looking statements, including any statements or discussions regarding the
completed merger transaction (the &#147;Coherent Merger&#148;) <FONT STYLE="white-space:nowrap">between&nbsp;II-VI&nbsp;and</FONT> Coherent, Inc., a Delaware corporation (&#147;Coherent&#148;), expected benefits of the Coherent Merger and the future
operating or financial performance of&nbsp;the combined company. All forward-looking statements are management&#146;s present expectations or forecasts of future events and are subject to a number of factors and uncertainties that could cause actual
results to differ materially from those described in the forward-looking statements. In addition to the factors discussed under the caption &#147;Risk Factors&#148; beginning on page&nbsp;7 of this prospectus and the factors previously disclosed in
our reports filed with the SEC, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure of any one or more of the assumptions stated herein, in any prospectus supplement or related free
writing prospectus or in any document incorporated by reference to prove to be correct; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks relating to forward-looking statements and other &#147;Risk Factors&#148; discussed in <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2021 and additional risk factors that may be identified from time to time in future filings of <FONT
STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the substantial indebtedness <FONT STYLE="white-space:nowrap">II-VI</FONT> has incurred in connection with the
Coherent Merger and the need to generate sufficient cash flows to service and repay such debt; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that <FONT STYLE="white-space:nowrap">II-VI</FONT> may be unable to achieve expected synergies,
operating efficiencies and other benefits within the expected time-frames or at all and to successfully integrate Coherent&#146;s operations with those of <FONT STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that such integration may be more difficult, time-consuming or costly than expected or that
operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers or suppliers) may be greater than expected in connection with the Coherent Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">litigation and any unexpected costs, charges or expenses resulting from the Coherent Merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that disruption from the Coherent Merger materially and adversely affects the business and operations of
the combined company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential adverse reactions or changes to business relationships resulting from the completion of the Coherent
Merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of <FONT STYLE="white-space:nowrap">II-VI</FONT> to retain and hire key employees;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchasing patterns of customers and <FONT STYLE="white-space:nowrap">end-users;</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timely release of new products, and acceptance of such new products by the market; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the introduction of new products by competitors and other competitive responses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to assimilate recently acquired businesses, and
realize synergies, cost savings, and opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to devise and execute strategies to respond to
market conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks to realizing the benefits of investments in R&amp;D and commercialization of innovations;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> stock price will not trade in line with
industrial technology leaders; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks of business and economic disruption related to the currently ongoing
<FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak and any other worldwide health epidemics or outbreaks that may arise. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For any forward-looking statements made in this prospectus, any prospectus supplement or any related free writing prospectus or in any
documents incorporated by reference into this prospectus, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on
the forward-looking statements, which speak only as of the date of this prospectus or the dates of the documents incorporated by reference in this prospectus. Except as required by applicable law, we do not undertake to update these forward-looking
statements to reflect facts, circumstances, assumptions or events that occur after the date the forward-looking statements are made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, see the reports that we have filed with the SEC as described under &#147;Where You Can Find More
Information&#148; beginning on page&nbsp;30 of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>We expressly qualify in their entirety all forward-looking statements
attributable to us or any person acting on our behalf by the cautionary statements contained or referred to in this prospectus. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_3"></A>TRADEMARKS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have proprietary rights to trademarks used in the information incorporated by reference into this prospectus, which are important to our
business, many of which are registered under applicable intellectual property laws. Solely for convenience, trademarks and trade names referred to in the information incorporated by reference in this prospectus may appear without the &#147;<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>&#148; or &#147;<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>&#148; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest
extent possible under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies&#146; trade names, trademarks or service marks to imply a
relationship with, or endorsement or sponsorship of us by, any other companies. Each trademark, trade name or service mark of any other company appearing in this prospectus is the property of its respective holder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_4"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information contained elsewhere, or incorporated by reference, in this prospectus. This summary does not
contain all of the information that you should consider before deciding to invest in the Common Stock and/or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. You should carefully read the entire prospectus, any
accompanying prospectus supplement and any related free writing prospectus, including the risks of investing in our securities discussed under the heading &#147;Risk Factors&#148; contained herein and in any accompanying prospectus supplement and
any related free writing prospectus, and under a similar heading in other documents that are incorporated by reference into this prospectus. You also should carefully read the information incorporated by reference into this prospectus, including our
financial statements and pro forma financial information contained in this prospectus or incorporated by reference, and the exhibits to the registration statement of which this prospectus is a part. Unless the context otherwise <FONT
STYLE="white-space:nowrap">requires,&nbsp;II-VI&nbsp;Incorporated</FONT> is referred to herein, collectively with all of its subsidiaries, as the <FONT STYLE="white-space:nowrap">&#147;Company,&#148;&nbsp;&#147;II-VI,&#148;&nbsp;or</FONT>
&#147;we,&#148; &#147;us,&#148; or &#147;our.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI,&nbsp;a</FONT> global leader in materials, networking and lasers, is a vertically integrated
manufacturing company that develops, manufactures and markets engineered materials, optoelectronic components and devices, and lasers for use in industrial materials processing, optical communications, aerospace and defense, consumer electronics,
semiconductor capital equipment, medical diagnostics and life sciences, automotive applications, machine tools, consumer goods and medical device manufacturing. Headquartered in Saxonburg,
<FONT STYLE="white-space:nowrap">Pennsylvania,&nbsp;II-VI&nbsp;has</FONT> research and development, manufacturing, sales, service, and distribution facilities worldwide. <FONT STYLE="white-space:nowrap">II-VI&nbsp;produces</FONT> a wide variety of
lasers, along with application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to enable its customers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated
in the Commonwealth of Pennsylvania on June&nbsp;22, 1971. Our corporate headquarters are located at 375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056. Our telephone number is <FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455.</FONT> Our
Internet website address <FONT STYLE="white-space:nowrap">is&nbsp;www.ii-vi.com.</FONT> The information contained on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus or to be part of this prospectus.
Our name is pronounced &#147;Two Six Incorporated,&#148; which refers to Groups II and VI on the periodic table of elements from which we originally designed and produced infrared optics for high-power carbon dioxide lasers used in materials
processing. You can obtain additional information regarding our business by reading our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;for</FONT> our most recent fiscal year ended June&nbsp;30, 2021, our subsequently filed
Quarterly Reports <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q&nbsp;and</FONT> the other reports we file with the SEC. See &#147;Where You Can Find More Information.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger Transaction and Financing Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Coherent Merger Agreement</I></B>. Pursuant to the Agreement and Plan of Merger (the &#147;Merger Agreement&#148;), dated as of
March&nbsp;25, 2021, by and among <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Watson Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary <FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;(&#147;Merger</FONT>
Sub&#148;), on July&nbsp;1, 2022, Merger Sub merged with and into Coherent (the &#147;Coherent Merger&#148;), with Coherent continuing as the surviving corporation in the Coherent Merger and a wholly owned subsidiary of <FONT
STYLE="white-space:nowrap">II-VI.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Merger Agreement, at the effective time of the Coherent Merger,
each share of common stock of Coherent issued and outstanding immediately prior to the effective time of the Coherent Merger (other than (i)&nbsp;shares of Coherent common stock owned
<FONT STYLE="white-space:nowrap">by&nbsp;II-VI,&nbsp;Coherent,</FONT> or any direct or indirect wholly owned subsidiary <FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;or</FONT> Coherent or (ii)&nbsp;shares of Coherent common stock owned by
stockholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
who properly exercised and perfected appraisal rights under Delaware law, in each case immediately prior to the effective time of the Coherent Merger), were cancelled and extinguished and
automatically converted into the right to receive (x) $220.00 in cash, without interest, plus (y) 0.91 of a share of our Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Issuance Of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </I></B>On the closing date of the Coherent
Merger, the Company issued and sold 140,000 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock for $10,000 per share and an aggregate purchase price of $1.4&nbsp;billion, pursuant to the Amended and Restated
Investment Agreement, dated as of March&nbsp;30, 2021 (as it may be amended from time to time, the &#147;Investment Agreement&#148;), by and between&nbsp;the Company and BCPE Watson (DE) SPV, LP, a Delaware limited partnership (&#147;BCPE&#148; and,
together with its successor and any respective affiliate thereof that becomes an investor party to the Investment Agreement, the &#147;Investors&#148;), and the Statement with Respect to Shares (as defined herein), upon the closing of which BML, an
affiliate of BCPE, became the beneficial owner of 75,000 of such shares and ORML, an affiliate of BCPE, became the beneficial owner of 65,000 of such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Senior Credit Facilities</I></B>. Also on the closing date of the Coherent Merger, the Company entered into a Credit Agreement, by and
among the Company, the lenders and other parties thereto, and JP Morgan Chase Bank, N.A., as administrative agent and collateral agent, which provides for senior secured financing of $4&nbsp;billion, consisting of a term loan A facility in an
aggregate principal amount of $850&nbsp;million, a term loan B facility in an aggregate principal amount of $2.8&nbsp;billion and a multicurrency revolving credit facility in an aggregate principal amount of up to $350&nbsp;million, including a
letter of credit <FONT STYLE="white-space:nowrap">sub-facility</FONT> of up to $50&nbsp;million (collectively, the &#147;Senior Facilities&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proceeds of the loans borrowed under the Senior Facilities on the closing date of the Coherent Merger, together with other financing sources
(including the Company&#146;s previously issued 5.000% senior notes due 2029) and cash on hand, were used to fund (i)&nbsp;the cash consideration payable in the Coherent Merger, (ii)&nbsp;the repayment in full of the Company&#146;s Amended and
Restated Credit Facility, dated as of September&nbsp;24, 2019, as amended, by and among the Company, the lenders party thereto and Bank of America, N.A., as administrative agent, and Coherent&#146;s Credit Agreement, dated as of November&nbsp;7,
2016, as amended, and (c)&nbsp;certain fees and expenses in connection with the Coherent Merger and otherwise for general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited Pro Forma Condensed Combined Financial Information</I></B><I>. </I>We have incorporated by reference into this prospectus
certain unaudited pro forma condensed combined financial information that gives effect to the Coherent Merger and related transactions as of the dates indicated therein. You should read the unaudited pro forma condensed combined financial
information in its entirety. See &#147;Where You Can Find More Information&#148; and &#147;Incorporation by Reference.&#148; The pro forma financial information has been presented for informational purposes only and is not necessarily indicative of
what the combined company&#146;s financial position or results of operations actually would have been had the Coherent Merger and the related transactions been completed as of the dates indicated. In addition, the pro forma financial information
does not purport to project the future financial position or operating results of the combined company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our Common Stock and/or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock involves risk. See
the risk factors described in our Annual Report <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-K&nbsp;for</FONT> our most recent fiscal year, together with those contained in subsequent filed Quarterly Reports
<FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q,&nbsp;and</FONT> those contained in our other filings with the SEC which are incorporated by reference in this prospectus or any accompanying prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the caption
&#147;Risk Factors&#148; in any applicable prospectus supplement or related free writing prospectus, together with all of the other information contained in any applicable prospectus supplement or related free writing prospectus or appearing or
incorporated by reference in this prospectus or any applicable prospectus supplement. These risks could materially affect our business, results of operations or financial condition and cause the value of our securities to decline. You could lose all
or part of your investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock ranks junior to all of our and our subsidiaries&#146;
consolidated liabilities, other than certain pari passu obligations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a voluntary or involuntary liquidation,
dissolution, <FONT STYLE="white-space:nowrap">or&nbsp;winding-up&nbsp;of</FONT> our affairs (a &#147;Liquidation Event&#148;), our assets will be available to pay obligations on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock (on a<I>&nbsp;pari passu</I>&nbsp;basis with obligations on our 6% Series A Mandatory Convertible Preferred Stock, no par value per share (the &#147;Series A Preferred Stock&#148;), and our
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Convertible Preferred Stock, no par value per share <FONT STYLE="white-space:nowrap">(&#147;Series&nbsp;B-1</FONT> Convertible Preferred Stock&#148;), only after all of our consolidated
liabilities have been paid. In addition, the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock ranks structurally junior to all existing and future liabilities of our subsidiaries. In the event of a Liquidation
Event, there may not be sufficient assets remaining, after paying our and our subsidiaries&#146; liabilities, to pay amounts due on any or all of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock then
outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2022, (i) our total consolidated indebtedness was approximately $2.3&nbsp;billion, of which an
aggregate of approximately $1.0&nbsp;billion was secured indebtedness of ours, to which the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock would have been subordinated ($1.0 billion of such indebtedness was
repaid on July&nbsp;1, 2022 in connection with the Coherent Merger), (ii)&nbsp;shares of our Series A Preferred Stock with aggregate stated value of approximately $445&nbsp;million were outstanding and (iii) 75,000 shares of our Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock with aggregate stated value of approximately $788&nbsp;million were outstanding. In connection with the closing of the Coherent Merger, (x)&nbsp;we issued 140,000 shares of our Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock with an aggregate stated value of $1.4&nbsp;billion and (y)&nbsp;we borrowed $3.7&nbsp;billion under the Senior Credit Facilities, all of which was secured indebtedness of ours,
to which the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is subordinated. In addition, we have the ability to, and may, incur additional indebtedness in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An active trading market for the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock does not exist and may not develop.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock has no established trading market and is
not listed on any securities exchange. Prior to July&nbsp;1, 2032 <FONT STYLE="white-space:nowrap">(the&nbsp;ten-year&nbsp;anniversary</FONT> of the date we issued the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock (the <FONT STYLE="white-space:nowrap">&#147;Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date&#148;), after which holders may require the Company to redeem shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock), investors seeking liquidity will be limited to selling their shares in the secondary market or converting their shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock into Common
Stock. We cannot assure you that an active trading market in the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will develop and, even if it develops, we cannot assure you that it will last. In either case, the
trading price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock could be adversely affected and holders&#146; ability to transfer shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock will be limited. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The market price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock will be directly affected by the market price of the Common Stock, which may be volatile. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that a secondary
market for the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock develops, we believe that the market price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be
significantly affected by the market price of the Common Stock. The trading price of the Common Stock may be highly volatile and could be subject to wide fluctuations in response to various factors, including (i)&nbsp;the risk factors described in
the section entitled &#147;Risk Factors&#148; contained in our Annual Report <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-K&nbsp;for</FONT> our most recent fiscal year, together with those contained in subsequent filed Quarterly Reports <FONT
STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q,&nbsp;and</FONT> those contained in our other filings with the SEC which are incorporated by reference into this prospectus or any applicable prospectus supplement and (ii)&nbsp;other factors which
are beyond our control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock market in general has experienced extreme price and volume fluctuations that have often
been unrelated or disproportionate to our business, financial condition or results of operations. Following periods of volatility in the market price of a company&#146;s securities, securities class action litigation could be initiated. If such
litigation were introduced against us, it could result in substantial costs and a diversion of our attention and resources, which could have a material adverse effect on our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot predict how shares of Common Stock will trade in the future, but fluctuations that may adversely affect the market prices of the
Common Stock (including those described under &#147;&#151;Additional Risks Related to the Common Stock&#148;), may, in turn, adversely affect the price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. This
may result in greater volatility in the market price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock than would be expected for nonconvertible preferred stock. In addition, we expect that the market price
of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be influenced by yield and interest rates in the capital markets and our perceived creditworthiness. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There may be future sales or other dilution of our equity, which may adversely affect the market price of the Common Stock or the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and may negatively impact the holders&#146; investment. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue additional shares of Common Stock, and, subject to the restrictions set forth in the Investment Agreement and the Statement with
Respect to Shares, additional shares of preferred stock including securities that are convertible into or exchangeable for, or that represent the right to receive, such securities, Common Stock or any substantially similar securities. The market
price of the Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock could decline as a result of sales of a large number of shares of Common Stock, additional preferred stock or similar securities in the
market or the perception that such sales could occur. For example, if we issue additional preferred stock in the future that has a preference over the Common Stock with respect to the payment of dividends or upon a Liquidation Event, or if we issue
additional preferred stock with voting rights that dilute the voting power of the Common Stock, the rights of holders of the Common Stock or the market price of the Common Stock could be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, the shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock and
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (together, the &#147;Series B Convertible Preferred Stock&#148;) have voting rights, voting as one class with Common Stock, on
<FONT STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis,</FONT> subject to limited exceptions. As a result, the issuance of the Series&nbsp;B Convertible Preferred Stock resulted in the immediate and substantial dilution to the interests of
the holders of the Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the conversion price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock is initially $85.00 per share, subject to adjustments as set forth in the Statement with Respect to Shares. For more information on the terms of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock, see &#147;Description of Capital <FONT STYLE="white-space:nowrap">Stock&#151;Series&nbsp;B-2</FONT> Convertible Preferred Stock.&#148; Any sales in the public market of the Common Stock issuable upon conversion of the Series&nbsp;B
Convertible Preferred Stock could adversely affect prevailing market prices of the Common Stock. Sales by holders of a substantial number of shares of Common Stock in the public market, or the perception that such sales might occur, could have a
material adverse effect on the price of the Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock has not been
rated. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock has not been rated by any
nationally recognized statistical rating organization. This may affect the market price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock may be redeemed at the option of the holder only in limited
circumstances. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will have the
option to require us to redeem such holder&#146;s shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock at any time on or after July&nbsp;1, 2032, the ten year anniversary of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date. As a result, holders of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock may be required to bear the financial
risks of an investment in the Series&nbsp;B-2 Convertible Preferred Stock for an extended period of time. See &#147;Description of Capital Stock&#151;Series&nbsp;B-2 Convertible Preferred Stock&#151;Redemption Option.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have the right, but not the obligation, to redeem shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock in
limited circumstances. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have the right, but are not required, to redeem, in whole or in part, on a pro rata basis from all
holders of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, the outstanding shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock at any time on or after the ten year
anniversary of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date. Therefore, holders should not expect that they have a right to perpetual payment of dividends and should be aware that a proposed
redemption of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock may make it difficult or impossible to sell shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock for a
higher price, even if the market price for such shares had previously been higher. See &#147;Description of Capital <FONT STYLE="white-space:nowrap">Stock&#151;Series&nbsp;B-2</FONT> Convertible Preferred Stock&#151;Redemption Option.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is subject to conversion at our option in certain circumstances
based on the trading price of the Common Stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time after the three year anniversary of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date, if the closing sale price of the Common Stock exceeds 150% of the then-applicable conversion price of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock for 20 trading days in any 30 consecutive trading day period, we may elect to convert all of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock at the then-applicable conversion price in accordance with the terms of the Statement with Respect to Shares. Following any such conversion, a holder will no longer be entitled to the dividend or other rights associated with the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. See &#147;Description of Capital <FONT STYLE="white-space:nowrap">Stock&#151;Series&nbsp;B-2</FONT> Convertible Preferred Stock&#151;Conversion.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The conversion price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock may not be adjusted for all dilutive
events that may adversely affect the market price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock or the Common Stock issuable upon conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of Common Stock that holders are entitled to receive upon conversion of a share
of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is subject to adjustment for certain events, including splits and combinations of the Common Stock, certain dividends and distributions on the Common Stock,
capital reorganizations or reclassifications, mergers or reorganizations, or rights offerings. However, there can be no assurance that an event that adversely affects the value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock, but does not result in an adjustment to the conversion price, will not occur. Further, if any of these other events adversely affects the market price of the Common Stock, it may also adversely affect the market price of
the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. In addition, we are generally not restricted by the terms of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock from
offering Common Stock in the future or engaging in other transactions that may dilute the Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders may have to pay taxes if we adjust the conversion rate of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock in certain circumstances, even though holders would not receive any cash. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon certain adjustments to (or certain failures to make adjustments to) the conversion price of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, holders may be deemed to have received a distribution from us, resulting in taxable income to them for U.S. federal income tax purposes, even though holders would
not receive any cash in connection with such adjustment to (or failure to adjust) the conversion price. If you are <FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.</FONT> holder (as defined in &#147;Material U.S. Federal Income Tax
Considerations&#148;) of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, any deemed dividend may be subject to U.S. federal withholding tax at a 30% rate, or such lower rate as may be specified by an
applicable treaty. Please consult your tax advisor and read &#147;Material U.S. Federal Income Tax Considerations&#148; regarding the U.S. federal income tax consequences of an adjustment to the conversion rate of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Accrued dividends with respect to the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock may be treated as taxable dividends even though holders would not receive any cash. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be accrued rather than paid for a
certain period of time and thereafter at the Company&#146;s sole discretion. Such accrued dividends will be added to the stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock under the terms of such
stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tax treatment of dividends accrued on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock
is a matter of uncertainty and may depend, in part, on whether the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as participating in corporate growth to any significant extent as determined under the
applicable Treasury Regulations. Pursuant to the Investment Agreement, the Company takes the position that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be treated as participating in corporate growth
to a significant extent. This position, however, is not free from doubt and there can be no assurance that the Internal Revenue Service (the &#147;IRS&#148;) will not take the position that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock should not be treated as participating in corporate growth to any significant extent as determined under the Treasury Regulations. In the event the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock is treated as not participating in corporate growth to any significant extent, the unpaid accrued dividends may be treated as a taxable distribution to the holder, even though the holder would not receive any cash or property in
connection with the increase in accrued dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock is treated as participating in corporate growth to a significant extent, if cash distributions are made on the common stock, the tax treatment of an increase in the stated value of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is not entirely clear. Such an increase may be a taxable distribution to the holder, if a cash distribution is made on our Common Stock within 36 months before or
after an increase in the stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and such distribution is treated as having caused a disproportionate distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please consult your tax advisor and read &#147;Material U.S. Federal Income Tax Considerations&#148; regarding the material U.S. federal
income tax consequences of the accrual of dividends on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Risks Related to the Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The
market price of the Common Stock could be negatively affected by sales of substantial amounts of the Common Stock in the public market. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future sales by the selling securityholders or others of substantial amounts of the Common Stock in the public market, or the perception that
these sales may occur, could cause the market price of the Common Stock to decline. These sales also could impede our ability to raise future capital. If any holders cause a large number of securities to be sold in the public market, including
Common Stock issuable upon conversion of the Series&nbsp;B Convertible Preferred Stock, the sales could reduce the trading price of the Common Stock. We cannot predict </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the size of future sales of shares of Common Stock or the effect, if any, that future sales, or the perception that such sales may occur, would have on the market price of Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The market price of the Common Stock may decline in the future as a result of the Coherent Merger. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of the Common Stock may decline in the future as a result of the Coherent Merger for a number of reasons, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the unsuccessful integration of Coherent <FONT STYLE="white-space:nowrap">and&nbsp;II-VI;&nbsp;and</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure of the combined company to achieve the perceived benefits of the Coherent Merger, including financial
results, as rapidly as or to the extent anticipated by financial or industry analysts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of these factors are beyond
the control <FONT STYLE="white-space:nowrap">of&nbsp;II-VI.</FONT> As a consequence, holders of Common Stock could lose all or portion of the value of their investment in Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of any shares of Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock by the selling securityholders, but we have agreed to pay certain registration expenses, other than underwriting discounts and commissions, applicable transfer taxes and the fees and expenses of any auditor or those of
more than one legal counsel engaged by the selling securityholders, in connection with offerings by the selling securityholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_7"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2022, the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date, we issued 140,000
shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, pursuant to the Investment Agreement and the Statement with Respect to Shares setting forth the terms of
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March&nbsp;30, 2021 (the &#147;Statement with Respect to Shares&#148;). On
such date, BML became the beneficial owner of 75,000 of such shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and ORML became the beneficial owner of 65,000 of such shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. The selling securityholders may from to time offer and sell pursuant to this prospectus any or all of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock, and any or all of the shares of Common Stock issuable upon the conversion of such shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the securities offered by this prospectus on behalf of the selling securityholders pursuant to the Registration Rights
Agreement, dated as of March&nbsp;31, 2021, as amended by Amendment No.&nbsp;1, dated as of July&nbsp;16, 2021, by and between the Company and BCPE (together with any joinder thereto from time to time, the &#147;Registration Rights Agreement&#148;).
Unless the context otherwise requires, as used in this prospectus, &#147;selling securityholders&#148; includes BML and ORML, certain of their affiliates to whom shares may be transferred in compliance with the Investment Agreement and any lenders
selling shares received from BML or ORML, as applicable, after the date of this prospectus following a foreclosure by the relevant lenders under any margin loan agreement constituting Back Leverage (as defined in the Investment Agreement) entered
into by BML or ORML, as applicable, which affiliate or lender agrees to be bound by the Registration Rights Agreement, and any such persons will be named in the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BML is the beneficial owner of 75,000 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock registered
herein and ORML is the beneficial owner of 65,000 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock registered herein. BCPE Watson (DE) BML GP, LLC (&#147;BML GP&#148;) is the general partner of BML. BCPE
Watson (DE) ORML GP, LLC (&#147;ORML GP&#148;) is the general partner of ORML. BCPE Watson (DE) Aggregator, LP (&#147;Aggregator&#148;) is the sole member of each of BML GP and ORML GP. Bain Capital Fund XII, L.P. (&#147;Fund XII&#148;) is the sole
member of BCPE Watson (DE) Aggregator GP, LLC, which is the general partner of Aggregator. Bain Capital Investors, LLC (&#147;BCI&#148;), is the manager of Bain Capital Partners XII, LLC, which is the general partner of Fund XII. As a result, BCI
may be deemed to share voting and dispositive power with respect to the 75,000 and 65,000 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock held by BML and ORML, respectively. Voting and investment decisions
with respect to the shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock held by BML and ORML are made by the managing directors of BCI. Each of the entities listed in this paragraph has a principal business
address c/o Bain Capital Private Equity, LP, 200 Clarendon Street, Boston, Massachusetts 02116. Additional information about selling securityholders, where applicable, will be set forth in a prospectus supplement, in a post-effective amendment or in
filings we make with the SEC under the Exchange Act that are incorporated by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling securityholders may from time to time
offer and sell pursuant to this prospectus shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock to be identified in a prospectus supplement, and any or all of the shares of Common Stock issuable upon
conversion of such shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each time a selling
securityholder sells shares of Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock using this prospectus, to the extent necessary, we will provide a prospectus supplement that will contain specific
information about the terms of that offering, the number of shares being offered, the manner of distribution, the identity of any underwriters or other counterparties and other specific terms related to the offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_8"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus, our authorized capital stock consists of 300,000,000 shares of Common Stock and 5,000,000 shares of
Preferred Stock, no par value per share (&#147;Preferred Stock&#148;). As of the close of business on July&nbsp;1, 2022, 129,627,276 shares of Common Stock were outstanding; 2,300,000 shares of Preferred Stock were designated as Series A Preferred
Stock, all of which were outstanding; and 215,000 shares of Preferred Stock were designated as Series B Convertible Preferred Stock, consisting of 75,000 shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Convertible Preferred Stock,
all of which were outstanding, and 140,000 shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, all of which were outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary description of the material terms of the securities being registered is based on the provisions of our Articles of
Incorporation, our Bylaws, the applicable provisions of the Pennsylvania Business Corporation Law (the &#147;BCL&#148;), and the Statement with Respect to Shares. This information may not be complete in all respects and is qualified entirely by
reference to the provisions of our Articles of Incorporation, Bylaws, the BCL and the Statement with Respect to Shares. For information on how to obtain copies of our Articles of Incorporation, Bylaws or the Statement with Respect to Shares, see
&#147;Where You Can Find More Information.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have one class of Common Stock. All holders of the Common Stock are entitled to the same rights and privileges as described below: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of shareholders. There is no cumulative
voting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividend and Liquidation Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of outstanding shares of Common Stock are entitled to receive dividends out of assets legally available for the payment of
dividends at the times and in the amounts as our board of directors may from time to time determine. Holders of Common Stock have no preemptive or subscription rights to purchase any of our securities and no sinking fund provisions apply to Common
Stock. Upon a Liquidation Event, the holders of Common Stock are entitled to receive pro rata the assets of the Company which are legally available for distribution, after payment of all debts and other liabilities and subject to the prior rights of
any holders of preferred stock of the Company then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never paid any cash dividends on Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Fully Paid <FONT STYLE="white-space:nowrap">and&nbsp;Non-Assessable</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Common Stock are fully paid <FONT STYLE="white-space:nowrap">and&nbsp;non-assessable.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Nasdaq Listing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock is listed on The Nasdaq Global Select Market (&#147;Nasdaq&#148;) under the symbol &#147;IIVI.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Transfer Agent and Registrar </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for the Common Stock is American Stock Transfer and Trust Company,&nbsp;LLC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>General</I></B>. Pursuant to the Articles of Incorporation, our board of directors has the authority, without further action by our
shareholders, to issue from time to time up to 5,000,000 shares of Preferred Stock in one or more series. Our board of directors may designate the rights, preferences, privileges, and restrictions of the preferred stock, including dividend rights,
conversion rights, voting rights, redemption rights, liquidation preference, sinking fund terms, and the number of shares constituting any series or the designation of any series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;30, 2021, we filed the Statement with Respect to Shares with the Pennsylvania Department of State Corporations Bureau,
establishing the designation, rights and preferences of the Series B Convertible Preferred Stock. The Statement with Respect to Shares became effective on March&nbsp;30, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Authorized Shares and Liquidation Preference</I></B>. Pursuant to the Statement with Respect to Shares, among other things, the Company
designated and established a series of Series B Convertible Preferred Stock as the <FONT STYLE="white-space:nowrap">&#147;Series&nbsp;B-2</FONT> Convertible Preferred Stock,&#148; with no par value per share, and a liquidation preference equal to
the greater of (i)&nbsp;the applicable stated value for such shares plus accrued or declared and unpaid dividends that had not previously been added to such stated value and (ii)&nbsp;the amount per share as would be payable in respect of Common
Stock upon the conversion of such shares, assuming all such outstanding shares were converted into Common Stock immediately prior to any Liquidation Event. The Statement with Respect to Shares provides that the number of shares constituting the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is 140,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ranking</I></B>. The Series B Convertible
Preferred Stock (including the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock) ranks, with respect to dividend rights and rights on the distribution of assets upon any Liquidation Event, (i)&nbsp;senior to the
Common Stock and each other class or series of our capital stock now existing or hereafter authorized, the terms of which do not expressly provide that such class or series ranks either (x)&nbsp;senior to the Series B Convertible Preferred Stock as
to dividend rights or distribution rights upon a Liquidation Event or (y)&nbsp;on parity with the Series B Convertible Preferred Stock as to dividend rights and distribution rights upon a Liquidation Event (such stock, &#147;Junior Stock&#148;),
(ii) on parity with our Series A Preferred Stock and each other class or series of our capital stock established after the initial issuance of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Convertible Preferred Stock (which occurred on
March&nbsp;31, 2021) (the &#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock Issuance Date&#148;), the terms of which expressly provide that such class or series ranks on parity with the Series B Convertible
Preferred Stock as to dividend rights and distribution rights upon a Liquidation Event (such stock, &#147;Parity Stock&#148;), and (iii)&nbsp;junior to each class or series of our capital stock established after the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Convertible Preferred Stock Issuance Date, the terms of which expressly provide that such class or series ranks senior to the Series B Convertible Preferred Stock as to dividend rights or
distribution rights upon a Liquidation Event (such stock, &#147;Senior Stock&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends</I></B>. Dividends on each share of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will accrue on the stated value of such share at 5.00% per annum, subject to adjustments as set forth in the Statement with Respect to Shares. Dividends on each share of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will accrue daily from and after the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date, but will compound on a quarterly
basis on each Dividend Payment Date (as defined in the Statement with Respect to Shares), whether or not earned or declared and whether or not the Company has assets legally available to make payment thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until the first Dividend Payment Date after the fourth anniversary of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock Issuance Date, all dividend payments will compound and be added to the applicable stated value of such share on each Dividend Payment Date (a &#147;PIK Dividend&#148;). Following such fourth anniversary, dividends will be payable in
the form of, in the Company&#146;s sole discretion, (i)&nbsp;solely cash (if, as and when authorized by the Company&#146;s board of directors or any duly authorized committee thereof, to the extent permitted by applicable law), (ii) solely a PIK
Dividend or (iii)&nbsp;any combination of both. If, following such fourth anniversary, the Company does not elect to pay a dividend solely in cash or in any combination of cash and PIK Dividend, the Company will be deemed to have elected to pay such
dividend solely as a PIK Dividend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company&#146;s board of directors declares a dividend on the Common Stock in the form of any
shares of capital stock of a subsidiary of the Company that are, or, when issued, will be, listed or admitted for trading on a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
U.S. national security exchange, the holders of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be entitled to receive such shares of capital stock
payable on the shares of Common Stock issuable upon the conversion of such holders&#146; shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Conversion</I></B>. Each holder of shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock has the
right, subject to conversion procedures set forth in the Statement with Respect to Shares, to convert such shares into the number of shares of Common Stock equal to the applicable stated value of such shares divided by such shares&#146; conversion
price, with&nbsp;cash paid in lieu of fractional shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The conversion price of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is initially $85.00 per share, subject to adjustment as set forth in the Statement with Respect to Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time after the three year anniversary of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock
Issuance Date, if the closing sale price of the Common Stock exceeds 150% of the then-applicable conversion price of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock for 20 trading days in any 30 consecutive
trading day period, the Company may elect to convert all (but not less than all) of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock at the then-applicable conversion price in accordance with the terms of the
Statement with Respect to Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Fundamental Change</I></B>. Upon a Fundamental Change (as defined below), the Company is required
to make an offer, subject to the procedures set forth in the Statement with Respect to Shares, to repurchase, at the option and election of the holders of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, each
share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock then-outstanding at a purchase price per share in cash equal to (i)&nbsp;the stated value for such shares plus accrued or declared and unpaid dividends on
such shares that had not previously been added to the stated value plus (ii)&nbsp;if prior to the fifth anniversary of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date, the aggregate amount of all
dividends that would have been paid (subject to certain exceptions) on such shares from the date of repurchase through the fifth anniversary of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#147;Fundamental Change&#148; will have occurred: (i)&nbsp;if any &#147;person&#148; or &#147;group&#148;, as such terms are used in
the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) (other than the Company or its wholly-owned subsidiaries (including each of the foregoing&#146;s employee benefit plans)), has become a &#147;beneficial owner&#148; (as
defined in the Exchange Act), directly or indirectly, of more than 50% of total voting power of the Common Stock; (ii)&nbsp;upon the consummation of (x)&nbsp;any recapitalization, reclassification or change of the Common Stock (other than changes
from a combination, subdivision or change in par value of the Common Stock) because of which the Common Stock becomes convertible into or exchangeable for other securities, property or assets; (y)&nbsp;any combination of the Company or binding share
exchange pursuant to which the Common Stock becomes convertible into or exchangeable for other securities, property or assets; or (z)&nbsp;any transfer or disposition of at least substantially all of the consolidated assets of the Company and its
Subsidiaries, taken as a whole, to any person other than a wholly-owned subsidiary of the Company; or (iii)&nbsp;if the Common Stock ceases to be limited on the New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or
any of their respective successors). However, a transaction described in clause (i)&nbsp;or (ii)&nbsp;in the foregoing sentence will not be considered a Fundamental Change if at least 90% of the consideration received or to be received by the
holders of Common Stock (subject to certain exceptions) in connection with such transaction consists of shares listed on or that will be listed on (at the time of issuance or exchange) the New York Stock Exchange, the Nasdaq Global Select Market or
the Nasdaq Global Market (or any of their respective successors) and as a result of such transaction such consideration would have been the consideration that a holder of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock would have been entitled to receive if such holder had immediately converted its <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock prior to the transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption Option</I></B>. At any time on or after the ten year anniversary of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock Issuance Date and subject to the procedures set forth in the Statement with Respect to Shares, (i)&nbsp;each holder of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will have the right to require the Company to redeem all of such holder&#146;s shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock for cash at a price per share equal to the sum of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stated value for such share plus accrued or declared and unpaid dividends on such share that had not previously been added to the stated value (the &#147;Redemption Price&#148;) and (ii)&nbsp;the
Company will have the right to redeem, in whole or in part, on a pro rata basis from all holders of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, the outstanding shares of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, for cash, equal to the Redemption Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting</I></B>. The shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock have voting rights,
voting as one class with the Common Stock and the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, on <FONT STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis,</FONT> subject to limited exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Protective Covenants</I></B>. At any time Series B Convertible Preferred Stock is outstanding, the Company is not permitted to (unless
the holders of a majority of the Series B Convertible Preferred Stock issued and outstanding otherwise consent in writing), subject to certain exceptions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">alter or change the rights, preferences or privileges of the Series B Convertible Preferred Stock or amend,
modify or supplement any provision of the organizational documents of the Company in a manner that adversely affects the rights, powers, preferences or privileges of the Series B Convertible Preferred Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorize or issue any Senior Stock (or securities convertible into Senior Stock), or amend or alter the
Company&#146;s Articles of Incorporation to increase the number of authorized or issued shares of Series B Convertible Preferred Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decrease the number of authorized shares of Series B Convertible Preferred Stock; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue any shares of Series B Convertible Preferred Stock (other than pursuant to the Investment Agreement).
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, subject to certain exceptions, the Company is not permitted: (i)&nbsp;so long as the Investors continue to
own at least 5% of the aggregate number of shares of Series B Convertible Preferred Stock issued on the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock Issuance Date or the Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock Issuance Date, to pay any cash dividend on Common Stock (other than cash dividends in amount of up to $3.00 per share in calendar year 2021, increased by 5% each subsequent
year) and (ii)&nbsp;so long as the Investors continue to own at least 25% of the aggregate number of shares of Series&nbsp;B Convertible Preferred Stock that were issued on the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred
Stock Issuance Date or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock Issuance Date, to redeem, repurchase or otherwise acquire (or make or declare any dividend or distribution in respect of) any Junior Stock
(subject to certain exceptions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Transfer Agent and Registrar. </I></B>The transfer agent and registrar for the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock is American Stock Transfer and Trust Company,&nbsp;LLC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights
Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Registration Rights Agreement, the Company agreed to provide the Investors with certain customary
registration rights with respect to the shares of Series&nbsp;B Convertible Preferred Stock and the Common Stock issuable upon conversion thereof. The Registration Rights Agreement permits an Investor, among other things, to pledge its rights under
the Registration Rights Agreement in connection with Back Leverage, and, subject to the assignee agreeing to be bound by the Registration Rights Agreement, to assign its rights to such assignee in connection with a foreclosure under a pledge of
registrable securities pursuant to any Back Leverage. This registration statement of which this prospectus is a part was filed pursuant to our obligations under the Registration Rights Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Law Provisions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain
provisions of Pennsylvania law and our Articles of Incorporation and our Bylaws could make the acquisition of the Company by means of a tender offer, or the acquisition of control of the Company by means of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a proxy contest or otherwise, more difficult. These provisions, summarized below, are intended to discourage certain types of coercive takeover practices and inadequate takeover bids, and are
designed to encourage persons seeking to acquire control of the Company to negotiate with our board of directors. We believe that the benefits of increased protection against an unfriendly or unsolicited proposal to acquire or restructure the
Company outweigh the disadvantages of discouraging such proposals. Among other things, negotiation of such proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Pennsylvania State Law Provisions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are
subject to various anti-takeover provisions of the BCL. Many of these provisions are triggered if any person or group acquires, or discloses intent to acquire, 20% or more of a Pennsylvania corporation&#146;s voting power, subject to certain
exceptions. These provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide the other shareholders of the corporation with certain rights against the acquiring group or person;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrict the voting and other rights of the acquiring group or person; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that certain profits realized by the acquiring group or person from the sale of a corporation&#146;s
equity securities belong to and are recoverable by the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regardless of the amount of a person&#146;s
holdings, if a shareholder or shareholder group (including affiliated persons) would be a party to certain proposed transactions with the Company or would be treated differently from our other shareholders in certain proposed transactions, the BCL
requires approval by a majority of votes entitled to be cast by all shareholders other than the interested shareholder or affiliate group, unless the transaction is approved by independent directors or other criteria are satisfied. Furthermore,
under Pennsylvania law, a &#147;short-form&#148; merger of the Company cannot be implemented without the consent of our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as permitted by Pennsylvania law, an amendment to our Articles of Incorporation or other corporate action that is approved by
shareholders may provide mandatory special treatment for specified groups <FONT STYLE="white-space:nowrap">of&nbsp;non-consenting&nbsp;shareholders</FONT> of the same class. For example, an amendment to our Articles of Incorporation or other
corporate action may provide that shares of our Common Stock held by designated shareholders of record must be cashed out at a price determined by us, subject to applicable dissenters&#146; rights. In these cases, Pennsylvania law requires either a
special class vote or dissenters&#146; rights for holders of the group designated for special treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the BCL provides
that directors may, in discharging their duties, consider, to the extent they deem appropriate, the effects of any action upon shareholders, employees, suppliers, customers and the communities in which its offices are located. Directors are not
required to consider the interests of shareholders to a greater degree than other constituencies&#146; interests. The BCL expressly provides that the fiduciary duty of directors does not require the directors to redeem or modify any &#147;poison
pills&#148; or take action under the anti-takeover provisions of the BCL in order to allow or facilitate a potential change of control. We do not currently have a &#147;poison pill.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Provisions in our Articles of Incorporation and our Bylaws </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation and our Bylaws contain provisions that could make us a less attractive target for a hostile takeover and could
make more difficult or discourage a merger proposal, a tender offer or a proxy contest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that shareholder-nominated director nominees be nominated in advance of the meeting at which
directors are elected and that specific information be provided in connection with such nomination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our board of directors to issue additional shares of Common Stock or Preferred Stock without
shareholder approval; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain provisions requiring supermajority approval (at
<FONT STYLE="white-space:nowrap">least&nbsp;two-thirds&nbsp;of</FONT> the votes cast by all shareholders entitled to vote thereon, voting together as a single class). </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification of Directors and Executive Officers and Limitation on Liability </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pennsylvania statutory law regarding directors and officers insurance and indemnification is embodied in Chapter 17, Subchapter D (Sections
1741 through 1750) of the BCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1741 (relating to third-party actions) and 1742 (relating to derivative and corporate actions) of
the BCL provide that a business corporation may indemnify any director, officer, employee or agent who is or was a representative of, or serving at the request of, the corporation (referred to as a &#147;Representative&#148;), so long as the
Representative acted in good faith and with a reasonable belief that his or her actions were in the best interests, or not opposed to the best interests, of the corporation, and with respect to any criminal proceeding under Section&nbsp;1741 of the
BCL, the Representative must have had no reasonable cause to believe his or her conduct was unlawful. In general, the power to indemnify under these sections does not exist in the case of actions against a director or officer by or in the right of
the corporation if the person otherwise entitled to indemnification shall have been adjudged to be liable to the corporation unless it is judicially determined that, despite the adjudication of liability but in view of all the circumstances of the
case, the person is fairly and reasonably entitled to indemnification for specified expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1743 of the BCL provides
mandatory indemnification for a Representative if he or she succeeds on the merits or otherwise in the defense of any claim or action or proceeding, or in defense of any claim, issue or matter therein. The corporation must indemnify him or her to
the extent of his or her actual and reasonable expenses (including attorneys&#146; fees) incurred in connection with the claim or action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1745 of the BCL states that expenses (including attorneys&#146; fees) incurred in defending any third-party or derivative action
or proceeding may be paid by a business corporation in advance of the final disposition of the action or proceeding upon receipt of an undertaking by or on behalf of the Representative to repay the amount if it is ultimately determined that such
person is not entitled to be indemnified by the corporation as authorized by the BCL or otherwise. Except as otherwise provided in the corporation&#146;s articles or bylaws, advancement of expenses must be authorized by the board of directors of the
corporation. The BCL provisions ordinarily governing transactions with interested directors or officers, or interested shareholders (Sections 1728 and 2538 of the BCL) do not apply to the authorization of advancement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1746(a) states that the statutory rights of indemnification and advancement of expenses shall not be deemed exclusive of any
other rights to which a person might be entitled under any bylaw, agreement, vote of shareholders or disinterested directors, or otherwise, both as to the action in his or her official capacity and as to the action or proceeding in another capacity
while holding that office. Section&nbsp;1746(c) specifies that indemnification pursuant to Section&nbsp;1746(a) may be made even if the corporation would not have the power to make such indemnification under other provisions of law, and may be made
even in the case of an action by or in the right of the corporation. Such indemnification is declared to be consistent with Pennsylvania&#146;s public policy. However, Section&nbsp;1746(b) forbids indemnification under subsection 1746(a) to be made
in any case where the act or failure to act giving rise to the claim is determined by a court to be willful misconduct or recklessness. A corporation&#146;s articles of incorporation may not provide for indemnification in the case of willful
misconduct or recklessness. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The BCL, in Section&nbsp;1747, also authorizes corporations to purchase and maintain
insurance on behalf of a Representative or a person who is or was serving at the request of the corporation as a Representative of another domestic or foreign entity, whether or not the corporation would have the power to indemnify him or her,
unless otherwise restricted in its bylaws. Such insurance is declared to be consistent with Pennsylvania&#146;s public policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1750 of the BCL provides that the indemnification and advancement of expenses provided by, or granted pursuant to Subchapter D of
the BCL shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a Representative and shall inure to the benefit of the heirs and personal representatives of that person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02 of our&nbsp;Bylaws provides that a director will not be personally liable for monetary damages for any action taken, or any
failure to take any action, unless the director has breached or failed to perform the duties of his or her office under Section&nbsp;9.01 of our Bylaws (relating to standard of care and justifiable reliance) and the breach or failure to perform
constitutes self-dealing, willful misconduct or recklessness. A director&#146;s criminal or tax liability is not limited by the foregoing provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03 of our&nbsp;Bylaws requires&nbsp;the Company&nbsp;to indemnify any director or officer of&nbsp;the Company&nbsp;to the
fullest extent not prohibited by law in connection with any actual or threatened action, suit or proceeding for indemnification, or that may give rise to indemnification, that (i)&nbsp;is brought against a person entitled to indemnification under
Article IX of our&nbsp;Bylaws, and (ii)&nbsp;arises out of the service of that person to&nbsp;the Company,&nbsp;or to another enterprise at the request of&nbsp;the Company&nbsp;(referred to as an &#147;indemnification action&#148;). The
Company&nbsp;may not indemnify any director or officer in connection with an indemnification action initiated by that director or officer (other than a successful indemnification action to enforce that individual&#146;s right to indemnification
under our&nbsp;Bylaws) unless the&nbsp;Board authorizes the indemnification action. The right to indemnification under Section&nbsp;9.03 includes the right to be reimbursed for expenses before the final disposition of an indemnification action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06 of our Bylaws permits&nbsp;the Company&nbsp;to purchase insurance to protect against any liability asserted against&nbsp;the
Company&nbsp;or any individual, whether or not&nbsp;the Company&nbsp;would have the power to indemnify that individual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company&nbsp;has entered into agreements with its directors and officers pursuant to which&nbsp;the Company&nbsp;has agreed to provide for the indemnification of and the advancing of expenses to each such indemnitee to the fullest extent (whether
partial or complete) permitted by law and as set forth in the applicable agreement, and, to the extent insurance is maintained, for the continued coverage of each such indemnitee under&nbsp;the Company&#146;s&nbsp;directors&#146; and officers&#146;
liability insurance policies. To the fullest extent permissible by applicable law, if the indemnification provided for in each such agreement is unavailable to the applicable indemnitee for any reason whatsoever,&nbsp;the Company,&nbsp;in lieu of
indemnifying such indemnitee, shall contribute to the amount incurred such indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for expenses, in connection with any claim relating to an
indemnifiable event under such agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such claim in order to reflect (i)&nbsp;the relative benefits received by&nbsp;the Company&nbsp;and such indemnitee
as a result of the event(s) and/or transaction(s) giving rise to such claim; and/or (ii)&nbsp;the relative fault of&nbsp;the Company&nbsp;(and its directors, officers, employees and agents) and such indemnitee in connection with such event(s) and/or
transaction(s). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offered securities are being registered to permit the holders of the offered securities the ability to offer and sell the offered
securities from time to time after the date of this prospectus. We will not receive any of the proceeds from the offering by the selling securityholders of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and
the Common Stock. We will bear the fees and expenses incurred by us in connection with our obligation to register the offered securities. If the securities are sold through underwriters or broker-dealers, the selling securityholders will be
responsible for underwriting discounts, selling commissions or stock transfer taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities offered hereby may be sold from time
to time in one or more transactions at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale or at negotiated prices. These prices will be
determined by the selling securityholders or by agreement between such holders and underwriters or dealers who may receive fees or commissions in connection with such sale. Such sales may be effected by a variety of methods, including the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in market transactions, including transactions on a national securities exchange or quotations service <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">or&nbsp;over-the-counter&nbsp;market;</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a block trade in which a broker-dealer will attempt to sell a block of securities as agent but may position
and resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the settlement of short sales, in each case subject to compliance with the Securities Act and other
applicable securities laws; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through one or more underwriters on a firm commitment or best-efforts basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">broker-dealers may agree with the selling securityholders to sell a specified number of such securities at a
stipulated price per security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any combination of the above or by any other legally available means. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling securityholders may enter into derivative transactions with third parties or sell securities not covered by this prospectus to
third parties in privately negotiated transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling securityholders may enter into hedging transactions with broker-dealers,
which may in turn engage in short sales of the offered securities, short and deliver the securities to close out such short positions, or loan or pledge the securities that in turn may sell such securities. The selling securityholders also may
transfer, donate and pledge offered securities, in which case the transferees, donees, pledgees or other successors in interest may be deemed selling securityholders for purposes of this transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To our knowledge, there are currently no plans, arrangements or understandings between the selling securityholders and any underwriter,
broker-dealer or agent regarding the sale by the selling securityholders of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the offered securities. The selling securityholders may decide to sell all or a portion of the securities offered by it pursuant to this prospectus or may decide not to sell any securities under
this prospectus. In addition, the selling securityholders may transfer sell, transfer or devise the securities by other means not described in this prospectus. Any securities covered by this prospectus that qualify for sale pursuant to Rule 144
under the Securities Act (&#147;Rule 144&#148;) may be sold pursuant to Rule 144 rather than pursuant to this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters,
broker-dealers (including selling securityholders who are registered broker-dealers) or agents participating in the distribution of the offered securities are deemed to be &#147;underwriters&#148; within the meaning of the Securities Act. Selling
securityholders, including those who are affiliates of registered broker-dealers, may be deemed to be underwriters within the meaning of the Securities Act. Profits on the sale of securities by selling securityholders, and any commission received by
any other underwriter, broker-dealer or agent, may be deemed to be underwriting commissions under the Securities Act. Selling securityholders that are deemed to be underwriters are subject to statutory liabilities, including, but not limited to,
those of Sections 11, 12 and 17 of the Securities Act and <FONT STYLE="white-space:nowrap">Rule&nbsp;10b-5&nbsp;under</FONT> the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling securityholders and any other person participating in the distribution will be subject to the applicable provisions of the
Exchange Act and the rules and regulations under the Exchange Act, including, without limitation, Regulation M, which may limit the timing of purchases and sales by the selling securityholders and any other relevant person of any of the securities.
Furthermore, Regulation M may restrict the ability of any person engaged in the distribution of securities to engage in market-making activities with respect to the securities being distributed. All of the above may affect the marketability of the
securities and the ability of any person or entity to engage in market-making activities with respect to the securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent
required, the securities to be sold, the names of the selling securityholders, the respective purchase prices and public offering prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a
particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to comply with the securities laws of some states, if applicable, the securities must be sold in such jurisdictions only through
registered or licensed brokers or dealers. In addition, in some states the securities may not be sold unless it has been registered or qualified for sale in the applicable state or the Company complies with an available exemption from registration
or qualification requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Registration Rights Agreement, we have agreed to indemnify in certain circumstances the
selling securityholders against certain liabilities under the Securities Act. The selling securityholders have agreed to indemnify us in certain circumstances against certain liabilities, including certain liabilities under the Securities Act. The
selling securityholders may indemnify any underwriter that participates in transactions involving the sale of shares of Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock against certain liabilities,
including liabilities arising under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Common Stock is listed on The Nasdaq Global Select Market under the symbol
&#147;IIVI.&#148; The <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is not listed on an exchange and we do not intend to list the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock on any exchange. On August 3, 2022, the closing price of our Common Stock as reported on The Nasdaq Global Select Market was $53.23 per share. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_10"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general discussion of the material U.S. federal income tax considerations with respect to the ownership, disposition and
conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and the ownership and disposition of any Common Stock received upon conversion of our <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock. This discussion is based on the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), U.S. Treasury Regulations and judicial decisions and administrative interpretations thereof, all as of the date hereof and
all of which are subject to change, possibly with retroactive effect. This discussion is limited to investors that hold the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (and the Common Stock) as capital assets
(generally, assets held for investment) for U.S. federal income tax purposes. Furthermore, this discussion does not address all aspects of U.S. federal income taxation that may be applicable to investors in light of their particular circumstances,
or to investors subject to special treatment under U.S. federal income tax law, such as financial institutions, insurance <FONT STYLE="white-space:nowrap">companies,&nbsp;tax-exempt&nbsp;organizations,</FONT> entities that are treated as
partnerships for U.S. federal income tax purposes, dealers in securities or currencies, expatriates, persons deemed to sell the convertible preferred stock under the constructive sale provisions of the Code, controlled foreign corporations, passive
foreign investment companies, qualified foreign pension funds, persons that hold the convertible preferred stock as part of a straddle, hedge, conversion transaction or other integrated investment, holders who own or have owned (directly, indirectly
or constructively) five percent or more of our common stock (by vote or value), U.S. Holders (as defined below) whose functional currency is not the U.S. dollar and persons who are required to recognize income for U.S. federal income tax purposes no
later than when such income is taken into account in applicable financial statements. Furthermore, this discussion does not address considerations relating to the alternative minimum tax, the unearned income Medicare contribution tax pursuant to the
Health Care and Education Reconciliation Act of 2010, the Foreign Account Tax Compliance Act of 2010 (including the U.S. Treasury Regulations promulgated thereunder and intergovernmental agreements entered into pursuant thereto), any U.S. federal
estate or gift tax consequences or any state, local or foreign tax consequences. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of those set forth below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is not intended to be tax advice. Potential investors should consult their tax advisors as to the particular U.S. federal
income tax consequences to them of the ownership, disposition and conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (and the ownership and disposition of any Common Stock received upon conversion
of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock), as well as the effects of other U.S. federal tax laws or state, local <FONT STYLE="white-space:nowrap">and&nbsp;non-U.S.</FONT> tax laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this summary, the term &#147;U.S. Holder&#148; means a beneficial owner of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (or Common Stock) other than a partnership or other entity or arrangement treated as a partnership for U.S. federal income tax purposes that is, for U.S. federal
income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, that is created or
organized under the laws of the United States, any of the states or the District of Columbia, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate the income of which is subject to U.S. federal income taxation regardless of its source, or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (A)&nbsp;if a court within the United States is able to exercise primary supervision over its
administration and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (B)&nbsp;that has made a valid election to be treated as a U.S. person for U.S. federal income tax purposes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this summary, the <FONT STYLE="white-space:nowrap">term&nbsp;&#147;Non-U.S.</FONT> Holder&#148; means a beneficial owner of
convertible preferred stock (or Common Stock), other than a partnership or other entity or arrangement treated as a partnership for U.S. federal income tax purposes, who is not a U.S. Holder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership (including any entity or arrangement treated as a partnership for U.S.
federal income tax purposes) owns the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (or Common Stock), the tax treatment of a partner in the partnership will depend upon the status of the partner and the
activities of the partnership. Partners in a partnership that owns the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (or Common Stock) should consult their tax advisors as to the particular U.S. federal income
tax consequences applicable to them. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distributions on the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, distributions of cash or property with respect to the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock, as applicable (other than accrued distributions on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, described below in &#147;&#151;Increases of the Stated Value of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock&#148;), will be subject to tax as dividends to the extent paid out of the Company&#146;s current or accumulated earnings and profits, as determined under U.S. federal
income tax principles. Such income will be includible in the gross income of a U.S. Holder as ordinary income on the day actually or constructively received by such holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that the amount of any distribution exceeds the Company&#146;s current and accumulated earnings and profits, as determined under
U.S. federal income tax principles, the excess will first be treated as <FONT STYLE="white-space:nowrap">a&nbsp;tax-free&nbsp;return</FONT> of capital, causing a reduction (but not below zero) in the adjusted tax basis of a U.S. Holder&#146;s Common
Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, as applicable. The amount of any remaining excess will be subject to tax as capital gain recognized on a sale or exchange as described below under
&#147;&#151;Taxable Dispositions.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-corporate&nbsp;U.S.</FONT> Holders will generally be
eligible for reduced rates of taxation on any dividend paid out of current and accumulated earnings and profits, provided that certain holding period and other requirements are satisfied. Corporate U.S. Holders will generally be eligible for a 50%
dividends-received deduction on any dividend paid out of current and accumulated earnings and profits, provided that certain holding period and other requirements are satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A dividend that exceeds certain thresholds in relation to a U.S. Holder&#146;s tax basis in the stock could be characterized as an
&#147;extraordinary dividend&#148; (as defined in Section&nbsp;1059 of the Code). If a corporate U.S. Holder receives an extraordinary dividend, it will generally be required to reduce (but not below zero) its stock basis in the shares in respect of
which the extraordinary dividend is paid by the portion of such dividend that is not taxed because of the dividends-received deduction. If the amount of the basis reduction exceeds the corporate U.S. Holder&#146;s tax basis in its stock, the excess
will be treated as taxable gain. If <FONT STYLE="white-space:nowrap">a&nbsp;non-corporate&nbsp;U.S.</FONT> Holder receives an extraordinary dividend, it will be required to treat any loss on the sale of the shares in respect of which such
extraordinary dividend is paid as a long-term capital loss to the extent of the extraordinary dividends received that qualify for the reduced dividend tax rate described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">U.S. Holders should consult their tax advisors regarding the availability of the reduced dividend tax rate or the dividends-received deduction
in light of their particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Increases of the Stated Value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The U.S. federal income tax treatment to a U.S. Holder of an increase in the stated value of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will depend on whether (1)&nbsp;the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as participating in corporate growth to
a significant extent as determined under applicable U.S. Treasury Regulations and (2)&nbsp;cash distributions are made on our Common Stock in a manner that causes a disproportionate distribution. Pursuant to the Investment Agreement, we take the
position that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be treated as participating in corporate growth to a significant extent and therefore as stock that is not &#147;preferred stock&#148; for
purposes of Section&nbsp;305 of the Code. This view, however, is not free from doubt, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and there can be no assurance that the IRS will agree that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock should be treated as participating in corporate
growth to a significant extent as determined under applicable U.S. Treasury Regulations. In general, a U.S. Holder is bound by our determination, unless the U.S. Holder explicitly discloses that it is taking a contrary position in a statement
attached to its timely filed tax return for the taxable year in which it acquires shares of our <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as participating in corporate
growth to a significant extent, if cash distributions are made on our Common Stock, the U.S. federal income tax treatment of an increase in the stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock
is not entirely clear. Such an increase may be a taxable distribution to the U.S. Holder, as described above under &#147;&#151;Distributions on the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock,&#148; if a cash distribution is made on shares of our Common Stock within 36 months before or after an increase in the stated value of the shares of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and
such distribution is treated as having caused a disproportionate distribution. U.S. Holders should consult their tax advisors regarding the U.S. federal income tax consequences of an increase in the stated value if we also make a cash distribution
on our Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as not
participating in corporate growth to a significant extent, whether or not cash distributions are also made on our Common Stock, the fair market value of the amount of increase in the stated value of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock may be treated as a taxable distribution to the U.S. Holder, as described above under &#147;&#151;Distributions on the Common Stock or
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock,&#148; in which case, the U.S. Holder&#146;s tax basis in its shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will
increase by the amount of any such taxable distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adjustment of Conversion Rate </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The conversion rate of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is subject to adjustment under
certain circumstances. A U.S. Holder of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will be treated as having received a constructive distribution includible in such holder&#146;s income in the manner
described under &#147;&#151;Distributions on the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock&#148; above, if and to the extent that certain adjustments (or failures to make adjustments) in
the conversion rate increase the U.S. Holder&#146;s proportionate interest in our earnings and profits. Thus, under certain circumstances, in the event of a deemed distribution, a U.S. Holder may recognize taxable income without receiving any cash
or property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock into Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A U.S. Holder will generally not recognize gain or loss upon the conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock into shares of Common Stock and cash in lieu of fractional shares, except that a U.S. Holder&#146;s receipt of cash in lieu of a fractional share of Common Stock will result in capital gain or loss (measured by the
difference between the cash received in lieu of the fractional share of Common Stock and the U.S. Holder&#146;s tax basis in the fractional share of Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A U.S. Holder&#146;s basis in shares of Common Stock received upon conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock (and any fractional shares of our Common Stock treated as received and then exchanged for cash) will generally equal the basis of the converted shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible
Preferred Stock and the holding period of such shares of Common Stock will include the holding period of the converted shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxable Dispositions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as
described above under &#147;&#151;Conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock into Common Stock&#148;, a U.S. Holder will generally recognize gain or loss on the sale, exchange, redemption,
retirement or other taxable disposition of the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock equal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the difference between the amount of cash and the fair market value of any property received upon the disposition and the U.S. Holder&#146;s adjusted tax basis in the Common Stock or the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. This gain or loss will generally be capital gain or loss, and will be long-term capital gain or loss if the U.S. Holder has held the Common Stock or the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock for more than one year. Otherwise, such gain or loss will be a short-term capital gain or loss. Long-term capital gains
<FONT STYLE="white-space:nowrap">of&nbsp;non-corporate&nbsp;U.S.</FONT> Holders are currently subject to tax at a reduced rate. The deductibility of capital losses is subject to limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Backup Withholding and Information Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, backup withholding (currently at a rate of 24%) may apply to a U.S. Holder with respect to payments of dividends on, and the
proceeds of the disposition of, shares of Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock if the U.S. Holder fails to provide a correct taxpayer identification number or otherwise comply with
the applicable requirements of the backup withholding rules and such U.S. Holder does not otherwise establish an exemption. Backup withholding is not an additional tax. Any amount withheld under the backup withholding rules may be credited against a
U.S. Holder&#146;s U.S. federal income tax liability (which may result in the U.S. Holder being entitled to a refund), provided that the required information is timely furnished to the IRS. In general, information reporting requirements may apply to
distributions on (including constructive distributions for U.S. federal income tax purposes), or to the proceeds of a disposition of, shares of Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock
received by a U.S. Holder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distributions on the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, distributions of cash or property with respect to the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock, as applicable (other than accrued distributions on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, described below in &#147;&#151;Increases of the Stated Value of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock&#148;), will be subject to tax as dividends to the extent paid out of the Company&#146;s current or accumulated earnings and profits, as determined under U.S. federal
income tax principles. To the extent that the amount of any distribution exceeds the Company&#146;s current and accumulated earnings and profits, as determined under U.S. federal income tax principles, the excess will first be treated as <FONT
STYLE="white-space:nowrap">a&nbsp;tax-free&nbsp;return</FONT> of capital, causing a reduction (but not below zero) in the adjusted tax basis of <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder&#146;s Common Stock or <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, as applicable. The amount of any remaining excess will be treated as capital gain realized on a sale or exchange as described below under &#147;&#151;Taxable
Dispositions.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions on our Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock that are treated as dividends, and that are not effectively connected with <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder&#146;s conduct of a trade or business in the United States, generally will be subject to withholding of
U.S. federal income tax at a 30% rate or lower rate as may be specified by an applicable income tax treaty. Dividends that are effectively connected with the conduct of a trade or business by <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT>
Holder within the United States (and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment) are not subject to withholding tax, provided certain certification and disclosure requirements (generally on an
IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI)&nbsp;are</FONT> satisfied. Instead, such dividends are subject to U.S. federal income tax on a net income basis in the same manner as if <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT>
Holder were a &#147;United States person&#148; as defined under the Code. Any such effectively connected dividends received by a foreign corporation may be subject to an additional &#147;branch profits tax&#148; at a 30% rate or such lower rate as
may be specified by an applicable income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.</FONT> Holder of the Common Stock
or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock who wishes to claim the benefits of an applicable income tax treaty will be required to provide IRS
<FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN&nbsp;or</FONT> IRS <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E&nbsp;(or</FONT></FONT> other applicable form) and certify under penalty of perjury that such
holder is not a &#147;United States person&#148; as defined under the Code and is eligible for income tax treaty benefits. Special certification and other requirements apply to <FONT STYLE="white-space:nowrap">certain&nbsp;Non-U.S.</FONT> Holders
that are pass-through entities rather than corporations or individuals or that hold their interests through certain intermediaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.</FONT> Holder of Common Stock or <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock eligible for a reduced rate of withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by filing an appropriate claim for a
refund with the IRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Increases of the Stated Value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The U.S. federal income tax treatment to <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder of an increase in the
stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will depend on whether (1)&nbsp;the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as
participating in corporate growth to a significant extent as determined under applicable U.S. Treasury Regulations and (2)&nbsp;cash distributions are made on our Common Stock in a manner that causes a disproportionate distribution. As discussed
above in &#147;&#151;U.S. Holders&#151;Increases of the Stated Value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock,&#148; we take the position the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock participates in corporate growth to a significant extent and therefore is stock that is not &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code. This view, however, is not free from doubt, and there
can be no assurance that the IRS will agree that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock should be treated as participating in corporate growth to a significant extent as determined under applicable
U.S. Treasury Regulations. In general, <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder is bound by our determination, unless <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder explicitly discloses that it is taking a
contrary position in a statement attached to its timely filed tax return for the taxable year in which it acquires shares of our <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming that the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as participating in corporate
growth to a significant extent, if cash distributions are made on our Common Stock, the U.S. federal income tax treatment of an increase in the stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock
is not entirely clear. Such an increase may be a taxable distribution to <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder, as described above under &#147;&#151;Distributions on the Common Stock or the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock,&#148; if a cash distribution is made on our Common Stock within 36 months before or after an increase in the stated value of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and such distribution is treated as having caused a disproportionate distribution. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax
advisors regarding the U.S. federal income tax consequences of an increase in the stated value if we also make a cash distribution on our Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock is treated as not participating in corporate growth
to a significant extent, whether or not cash distributions are also made on our Common Stock, the fair market value of the amount of increase in the stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock may be treated as a taxable distribution to <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder, as described above under &#147;&#151;Distributions on the Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock,&#148; in which case <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder&#146;s tax basis in such <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock will increase by the
amount of any such taxable distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adjustment of Conversion Rate </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above under &#147;&#151;U.S. Holders&#151;Adjustment of Conversion Rate,&#148; adjustments to the conversion rate (or failure to
make adjustments) that have the effect of increasing <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder&#146;s proportionate interest in our assets or earnings may, in some circumstances, result in a deemed distribution to <FONT
STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder that will be subject to tax as described above <FONT STYLE="white-space:nowrap">under&nbsp;&#147;&#151;Non-U.S.</FONT> Holders&#151;Distributions on the Common Stock or the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock.&#148; Any constructive dividend deemed paid to <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder will be subject to U.S. federal withholding tax at the rate
of 30%, unless reduced or eliminated by treaty. However, any constructive dividends that are effectively connected with the conduct of a trade or business by <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder within the United States
will be subject to tax as described above <FONT STYLE="white-space:nowrap">under&nbsp;&#147;&#151;Non-U.S.</FONT> Holders&#151;Distributions on the Common Stock or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred
Stock.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock into Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.</FONT> Holder will generally not recognize gain or loss in respect of the receipt of Common
Stock upon the conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock, except for the possible receipt of cash in lieu </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of fractional shares of Common Stock that will be subject to the treatment described below under &#147;&#151;Taxable Dispositions.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.</FONT> Holder&#146;s basis in shares of Common Stock received upon conversion of shares of
the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (and any fractional shares of our Common Stock treated as received and then exchanged for cash) will generally equal the basis of the converted shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and the holding period of such shares of Common Stock will include the holding period of the converted shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxable Dispositions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any gain realized on the disposition of the Common Stock (including any fractional share of Common Stock treated as received and then exchanged
for cash) or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock (other than a conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock into Common Stock) will generally
not be subject to U.S. federal income tax unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder&#146;s
conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder maintains a permanent establishment in the United States to which such
gain is attributable); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder is a nonresident alien individual present in the
United States for 183 days or more during the taxable year of the disposition and certain other requirements are met. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An <FONT
STYLE="white-space:nowrap">individual&nbsp;Non-U.S.</FONT> Holder described in the first bullet point immediately above will be subject to tax on the net gain derived from the sale under regular graduated U.S. federal income tax rates. An <FONT
STYLE="white-space:nowrap">individual&nbsp;Non-U.S.</FONT> Holder described in the second bullet point immediately above will be subject to a flat 30% tax on the gain derived from the sale, which may be offset by U.S. source capital losses, even
though the individual is not considered a resident of the United States. If <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder that is a foreign corporation falls under the first bullet point immediately above, it will be subject to tax
on its net gain in the same manner as if it were a United States person as defined under the Code and, in addition, may be subject to the branch profits tax equal to 30% of its effectively connected earnings and profits or at such lower rate as may
be specified by an applicable income tax treaty. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Backup Withholding and Information Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding (currently at a rate of 24%) will not apply to payments of dividends on our Common Stock or
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock to <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder if <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder provides to the applicable
withholding agent a properly executed IRS <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN&nbsp;or&nbsp;W-8BEN-E&nbsp;(or</FONT></FONT></FONT> other applicable form) certifying under
penalties of perjury that <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder is not a United States person, or otherwise qualifies for an exemption. However, the applicable withholding agent generally will be required to report to the
IRS and to <FONT STYLE="white-space:nowrap">such&nbsp;Non-U.S.</FONT> Holder payments of dividends on our Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock and the amount of U.S. federal income tax,
if any, withheld with respect to those payments. Copies of the information returns reporting such dividends and any withholding may also be made available to the tax authorities in the country in which
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder resides under the provisions of an applicable tax treaty or agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The gross proceeds from sales or other dispositions of shares of our Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT>
Convertible Preferred Stock may be subject, in certain circumstances discussed below, to U.S. backup withholding and information reporting. If <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder sells or otherwise disposes of shares of
our Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock outside the United States through <FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.</FONT> office of
<FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.</FONT> broker and the disposition proceeds are paid to <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder outside the United States, then the U.S. backup withholding and information
reporting requirements generally will not apply to that payment. However, U.S. information reporting, but not U.S. backup withholding, will apply to a payment of disposition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proceeds, even if that payment is made outside the United States, if <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder sells shares of our Common Stock or <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock through <FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.</FONT> office of a broker that is a United States person or has certain enumerated connections with the United
States, unless the broker has documentary evidence in its files that <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder is not a United States person and certain other conditions are met or
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder otherwise qualifies for an exemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
<FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.</FONT> Holder receives payments of the proceeds of a disposition of shares of our Common Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Convertible Preferred Stock to or through a
U.S. office of a broker, the payment will be subject to both U.S. backup withholding and information reporting unless <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder provides to the broker a properly executed IRS <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN&nbsp;or&nbsp;W-8BEN-E&nbsp;(or</FONT></FONT></FONT> other applicable form) certifying under penalties of perjury that <FONT
STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder is not a United States person, or <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder otherwise qualifies for an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amount withheld under the backup withholding rules may be credited against <FONT
STYLE="white-space:nowrap">the&nbsp;Non-U.S.</FONT> Holder&#146;s U.S. federal income tax liability (which may result in the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder being entitled to a refund), provided that the required information
is timely furnished to the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity and legality of the securities offered hereby and certain other legal matters will be passed upon for the Company by K&amp;L
Gates LLP, Pittsburgh, Pennsylvania. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B>. The consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT>
Incorporated and Subsidiaries appearing in <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended June&nbsp;30, 2021, and the effectiveness of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries&#146; internal control over financial reporting as of June&nbsp;30, 2021 (excluding the internal control over financial reporting of Ascatron AB and INNOViON Corporation), have
been audited by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, which as to the report on the effectiveness of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s
internal control over financial reporting contains an explanatory paragraph describing the above referenced exclusion of Ascatron AB and INNOViON Corporation from the scope of such firm&#146;s audit of internal control over financial reporting,
included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Coherent</B>. The financial statements of Coherent, Inc. incorporated by reference in this Prospectus by reference to Coherent, Inc.&#146;s
annual report on Form 10 K for the year ended October&nbsp;2, 2021, and the effectiveness of Coherent, Inc.&#146;s internal control over financial reporting, have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public
accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and special reports, proxy statements and other information with the SEC. You can read our SEC filings, including
the registration statement, at the SEC&#146;s website at www.sec.gov. Our web site is located <FONT STYLE="white-space:nowrap">at&nbsp;www.ii-vi.com.</FONT> The information contained on or accessible through our web site is not part of this
prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide, upon written or oral request, without charge to you, including any beneficial owner to whom this prospectus
is delivered, a copy of any or all of the documents incorporated herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the information that this prospectus incorporates.
You should direct a request for copies to us at Attention: Secretary, 375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056 or you may call us at <FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom388182_14"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus &#147;incorporates by reference&#148; certain information that we or others have filed with the SEC. This means we are
disclosing important information to you by referring you to those documents. We incorporate by reference the documents listed below and any future filings made by us with the SEC under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act until
the offering is terminated: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI&nbsp;Filings</FONT> (SEC&nbsp;File&nbsp;No.
<FONT STYLE="white-space:nowrap">001-39375)</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031822000010/iivi-20220331.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarterly period ended March&nbsp;31, 2022 filed with the SEC on May&nbsp;10, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on&nbsp;
<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031822000004/iivi-20211231.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT></A>&nbsp;for the quarterly period ended December&nbsp;31, 2021
filed with the SEC on February&nbsp;9, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q&nbsp;for</FONT> the quarterly period
ended September&nbsp;30, 2021, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031821000022/iivi-20210930.htm">November&nbsp;
9, 2021</A>, as amended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521325146/d252020d10qa.htm">November&nbsp;10, 2021</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual Report on&nbsp;
<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031821000017/iivi-20210630.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></A>&nbsp;for the fiscal year ended June&nbsp;30, 2021 filed with
the SEC on August&nbsp;20, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;filed</FONT> with the SEC on&nbsp;
<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521220024/d159418d8k.htm">July&nbsp;
21, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521237904/d205223d8k.htm">August&nbsp;
5, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521241180/d103542d8k.htm">August&nbsp;
10, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521246796/d208804d8k.htm">August&nbsp;
16, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521256850/d173489d8k.htm">August&nbsp;
26, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521323826/d244671d8k.htm">November&nbsp;
9, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521339339/d242818d8k.htm">November&nbsp;
24, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521346011/d230792d8k.htm">December&nbsp;
2, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312521353969/d243415d8k.htm">December&nbsp;
10, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522031889/d250294d8k.htm">February&nbsp;
9, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522046612/d212194d8k.htm">February&nbsp;
18, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522067965/d282053d8k.htm">March&nbsp;
7, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522077748/d334326d8k.htm">March&nbsp;
17, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522137818/d228839d8k.htm">May&nbsp;
3, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522145674/d298236d8k.htm">May&nbsp;
10, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522158505/d359980d8k.htm">May&nbsp;
24, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522183458/d338403d8k.htm">June&nbsp;
28, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522186770/d307343d8k.htm">July&nbsp;
1, 2022</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312522211867/d353059d8ka.htm">August 4, 2022</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portions of our&nbsp;Definitive Proxy Statement on Schedule 14A&nbsp;
filed on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521294198/d187295ddef14a.htm">October&nbsp;
7, 2021</A> that are specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031821000017/iivi-20210630.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;10-K
</FONT></A>&nbsp;for the fiscal year ended June&nbsp;30, 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of the Company&#146;s Common Stock contained in our Registration Statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;8-A</FONT> filed pursuant to Section&nbsp;12(b) of the Exchange Act as filed with the SEC on September&nbsp;14, 1987, including any subsequent amendments or reports filed for the purpose of updating such
description. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coherent Filings <FONT STYLE="white-space:nowrap">(SEC&nbsp;File&nbsp;No.&nbsp;001-33962)</FONT> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/21510/000002151022000023/cohr-20220402.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarterly period ended April&nbsp;2, 2022 filed with the SEC on May&nbsp;11, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/21510/000002151022000011/cohr-20220101.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT></A>&nbsp;for the quarterly period ended January&nbsp;1, 2022 filed with the SEC on February&nbsp;9, 2022; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual Report <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-K&nbsp;for</FONT> the fiscal year ended
October&nbsp;2, 2021 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/21510/000002151021000060/cohr-20211002.htm">November&nbsp;
30, 2021</A>, as amended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/21510/000110465921153555/tm2134970d1_10ka.htm">December&nbsp;27, 2021</A>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that any information contained in any report on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;or&nbsp;8-K/A,&nbsp;or</FONT></FONT> any exhibit thereto, was furnished to, rather than filed with, the SEC, such information or exhibit is specifically not
incorporated by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have authorized no one to provide you with information other than information incorporated by reference or
provided in this prospectus. You should not assume that the information in this prospectus is accurate as of any date other than the date on the front of this document. All documents that we file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of
the Exchange Act after the date of this prospectus or after the date of the registration statement of which this prospectus forms a part and prior to the termination of the offering will be deemed to be incorporated in this prospectus by reference
and will be a part of this prospectus from the date of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the filing of the document. Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed to be modified or superseded for
purposes of this prospectus to the extent that a statement contained in this prospectus or in any other subsequently filed document which also is or is deemed to be incorporated by reference in this prospectus modifies or supersedes that statement.
Any statement that is modified or superseded will not constitute a part of this prospectus, except as modified or superseded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Requests
for copies of any of the materials incorporated by reference in this prospectus should be directed to our Investor Relations department, at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">II-VI&nbsp;Incorporated</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">375 Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saxonburg,
Pennsylvania 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is an estimate of the expenses (all of which are to be paid by the registrant) that we may incur in connection with the
securities being registered hereby. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Registration Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasdaq Listing Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Agent Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">**&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rules 456(b) and 457(r) under the Securities Act, as amended, the SEC registration fee will be paid
at the time of any particular offering of securities under the registration statement, and is therefore not currently determinable. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These fees and expenses depend on the securities offered and the number of issuances and accordingly cannot be
estimated at this time. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INDEMNIFICATION OF DIRECTORS AND OFFICERS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pennsylvania statutory law regarding directors and officers insurance and indemnification is embodied in Chapter 17, Subchapter D (Sections
1741 through 1750) of the Pennsylvania Business Corporation Law (the &#147;BCL&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1741 (relating to third-party actions)
and 1742 (relating to derivative and corporate actions) of the BCL provide that a business corporation may indemnify any director, officer, employee or agent who is or was a representative of, or serving at the request of, the corporation (referred
to as a &#147;Representative&#148;), so long as the Representative acted in good faith and with a reasonable belief that his or her actions were in the best interests, or not opposed to the best interests, of the corporation, and with respect to any
criminal proceeding under Section&nbsp;1741 of the BCL, the Representative must have had no reasonable cause to believe his or her conduct was unlawful. In general, the power to indemnify under these sections does not exist in the case of actions
against a director or officer by or in the right of the corporation if the person otherwise entitled to indemnification shall have been adjudged to be liable to the corporation unless it is judicially determined that, despite the adjudication of
liability but in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnification for specified expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1743 of the BCL provides mandatory indemnification for a Representative if he or she succeeds on the merits or otherwise in the
defense of any claim or action or proceeding, or in defense of any claim, issue or matter therein. The corporation must indemnify him or her to the extent of his or her actual and reasonable expenses (including attorney&#146;s fees) incurred in
connection with the claim or action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1745 of the BCL states that expenses (including attorneys&#146; fees) incurred in
defending any third-party or derivative action or proceeding may be paid by a business corporation in advance of the final disposition of the action or proceeding upon receipt of an undertaking by or on behalf of the Representative to repay the
amount if it is ultimately determined that such person is not entitled to be indemnified by the corporation as authorized by the BCL or otherwise. Except as otherwise provided in the corporation&#146;s articles or bylaws,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advancement of expenses must be authorized by the board of directors of the corporation. The BCL provisions ordinarily governing transactions with interested directors or officers, or interested
shareholders (Sections 1728 and 2538 of the BCL) do not apply to the authorization of advancement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1746(a) states that the
statutory rights of indemnification and advancement of expenses shall not be deemed exclusive of any other rights to which a person might be entitled under any bylaw, agreement, vote of shareholders or disinterested directors, or otherwise, both as
to the action in his or her official capacity and as to the action or proceeding in another capacity while holding that office. Section&nbsp;1746(c) specifies that indemnification pursuant to Section&nbsp;1746(a) may be made even if the corporation
would not have the power to make such indemnification under other provisions of law, and may be made even in the case of an action by or in the right of the corporation. Such indemnification is declared to be consistent with Pennsylvania&#146;s
public policy. However, Section&nbsp;1746(b) forbids indemnification under subsection 1746(a) to be made in any case where the act or failure to act giving rise to the claim is determined by a court to be willful misconduct or recklessness. A
corporation&#146;s articles of incorporation may not provide for indemnification in the case of willful misconduct or recklessness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
BCL, in Section&nbsp;1747, also authorizes corporations to purchase and maintain insurance on behalf of a Representative or a person who is or was serving at the request of the corporation as a Representative of another domestic or foreign entity,
whether or not the corporation would have the power to indemnify him or her, unless otherwise restricted in its bylaws. Such insurance is declared to be consistent with Pennsylvania&#146;s public policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1750 of the BCL provides that the indemnification and advancement of expenses provided by, or granted pursuant to Subchapter D of
the BCL shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a Representative and shall inure to the benefit of the heirs and personal representatives of that person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02 <FONT STYLE="white-space:nowrap">of&nbsp;the&nbsp;II-VI&nbsp;bylaws&nbsp;provides</FONT> that a director will not be
personally liable for monetary damages for any action taken, or any failure to take any action, unless the director has breached or failed to perform the duties of his or her office under Section&nbsp;9.01
<FONT STYLE="white-space:nowrap">of&nbsp;the&nbsp;II-VI&nbsp;bylaws&nbsp;(relating</FONT> to standard of care and justifiable reliance) and the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness. A
director&#146;s criminal or tax liability is not limited by the foregoing provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03 of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws <FONT STYLE="white-space:nowrap">requires&nbsp;II-VI</FONT> to indemnify any director or officer of <FONT STYLE="white-space:nowrap">II-VI</FONT> to the fullest extent not prohibited by law in
connection with any actual or threatened action, suit or proceeding for indemnification, or that may give rise to indemnification, that (1)&nbsp;is brought against a person entitled to indemnification under Article IX of the bylaws, and
(2)&nbsp;arises out of the service of that person to <FONT STYLE="white-space:nowrap">II-VI,</FONT> or to another enterprise at the request of <FONT STYLE="white-space:nowrap">II-VI</FONT> (referred to as an &#147;indemnification action&#148;). <FONT
STYLE="white-space:nowrap">II-VI</FONT> may not indemnify any director or officer in connection with an indemnification action initiated by that director or officer (other than a successful indemnification action to enforce that individual&#146;s
right to indemnification under the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws) unless the <FONT STYLE="white-space:nowrap">II-VI</FONT> board authorizes the indemnification action. The right to indemnification under Section&nbsp;9.03
includes the right to be reimbursed for expenses before the final disposition of an indemnification action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06 of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws permits <FONT STYLE="white-space:nowrap">II-VI</FONT> to purchase insurance to protect against any liability asserted against <FONT STYLE="white-space:nowrap">II-VI</FONT> or any individual, whether or
not <FONT STYLE="white-space:nowrap">II-VI</FONT> would have the power to indemnify that individual. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI&nbsp;has&nbsp;entered</FONT> into agreements with its directors and officers pursuant to which <FONT
STYLE="white-space:nowrap">II-VI</FONT> has agreed to provide for the indemnification of and the advancing of expenses to each such indemnitee to the fullest extent (whether partial or complete) permitted by law and as set forth in the applicable
agreement, and, to the extent insurance is maintained, for the continued coverage of each such indemnitee <FONT STYLE="white-space:nowrap">under&nbsp;II-VI&#146;s</FONT> directors&#146; and officers&#146; liability insurance policies. To the fullest
extent permissible by applicable law, if the indemnification provided for in each such agreement is unavailable to the applicable indemnitee for any reason whatsoever, <FONT STYLE="white-space:nowrap">II-VI,</FONT> in lieu of indemnifying such
indemnitee, shall contribute to the amount incurred such indemnitee, whether for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for expenses, in connection with any claim relating to an indemnifiable event under such agreement, in
such proportion as is deemed fair and reasonable in light of all of the circumstances of such claim in order to reflect (i)&nbsp;the relative benefits received by&nbsp;II-VI and such indemnitee as a result of the event(s) and/or transaction(s)
giving rise to such claim; and/or (ii) the relative fault of <FONT STYLE="white-space:nowrap">II-VI</FONT> (and its directors, officers, employees and agents) and such indemnitee in connection with such event(s) and/or transaction(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indemnification described in the preceding paragraphs may include indemnification against liabilities arising under the Securities Act.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or <FONT STYLE="white-space:nowrap">persons&nbsp;controlling&nbsp;II-VI&nbsp;pursuant</FONT> to the foregoing <FONT
STYLE="white-space:nowrap">provisions,&nbsp;II-VI</FONT> has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXHIBITS </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312511302244/d253525dex31.htm">Amended and Restated Articles of Incorporation <FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;
Incorporated</FONT> (incorporated by reference to Exhibit 3.1 <FONT STYLE="white-space:nowrap">to&nbsp;II-VI&nbsp;Incorporated&#146;s</FONT> Current Report on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;
(File&nbsp;No.&nbsp;000-16195)&nbsp;filed</FONT></FONT> on November&nbsp;8, 2011). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521339339/d242818dex31.htm">Amended and Restated Bylaws <FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;
Incorporated</FONT> (incorporated by reference to Exhibit 3.1 <FONT STYLE="white-space:nowrap">to&nbsp;II-VI&nbsp;Incorporated&#146;s</FONT> Current Report on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;
(File&nbsp;No.&nbsp;001-39375)&nbsp;filed</FONT></FONT> on November&nbsp;24, 2021). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521102324/d135490dex31.htm">Statement with Respect to Shares, filed with the Pennsylvania Department of State Corporations Bureau and effective March&nbsp;
30, 2021 (incorporated by reference to Exhibit 3.1 to <FONT STYLE="white-space:nowrap">II-VI&nbsp;Incorporated&#146;s</FONT> Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;(File&nbsp;
No.</FONT> <FONT STYLE="white-space:nowrap">001-39375)&nbsp;filed</FONT> on March&nbsp;31, 2021). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521102324/d135490dex101.htm">Amended and Restated Investment Agreement, dated as of March&nbsp;30, 2021, by and between <FONT STYLE="white-space:nowrap">II-VI&nbsp;
Incorporated</FONT> and BCPE Watson (DE) SPV, LP (incorporated by reference to Exhibit 10.1 <FONT STYLE="white-space:nowrap">to&nbsp;II-VI&nbsp;Incorporated&#146;s</FONT> Current Report on <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;(File&nbsp;No.&nbsp;001-39375)&nbsp;filed</FONT></FONT> on March&nbsp;31, 2021). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;*5.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d388182dex51.htm">Opinion of K&amp;L Gates LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;23.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d388182dex51.htm">Consent of K&amp;L Gates LLP (included in Exhibit&nbsp;5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;*23.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d388182dex232.htm">Consent of Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm <FONT STYLE="white-space:nowrap">of&nbsp;II-VI.</FONT> </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;*23.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d388182dex233.htm">Consent of Deloitte&nbsp;&amp; Touche LLP, independent registered public accounting firm of Coherent, Inc. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;*24.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Powers of Attorney (included on signature page). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*107</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d388182dexfilingfees.htm">Filing Fee Table. </A></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNDERTAKINGS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the
most recent post-effective amendment thereof) which, individually or in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20&nbsp;percent change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration
statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>provided</I>,<I>&nbsp;however</I>, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to
be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the<I></I>&nbsp;SEC by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are
incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule&nbsp;424(b) that is part of the registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) That, for the purpose of determining liability under the Securities Act to any purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement
as of the date the filed prospectus was deemed part of and included in the registration statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule&nbsp;415(a)(1)(i), (vii), or (x)&nbsp;for the purpose of
providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the
date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new
effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
<I>Provided</I>,<I>&nbsp;however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part
of the registration statement or made in any such document immediately prior to such effective date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(5) That, for the purpose of
determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to
this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed
pursuant to Rule 424; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the
undersigned registrant or used or referred to by the undersigned registrant; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The portion of any other free writing
prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant&#146;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of
the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy The undersigned
registrant hereby undertakes that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) For purposes of determining any liability under the Securities Act, the information omitted from
the form of prospectus filed as part of this registration statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be
deemed to be part of this registration statement as of the time it was declared effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) For the purpose of determining any
liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3&nbsp;and</FONT> has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Borough of Saxonburg,
Commonwealth of Pennsylvania, on August 4, 2022. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vincent D. Mattera, Jr.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vincent D. Mattera, Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and Chairman of the Board</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY AND SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person whose signature appears below constitutes and appoints Vincent D. Mattera Jr., Mary Jane Raymond and Ronald Basso his or her true
and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">lawful&nbsp;attorneys-in-fact&nbsp;and</FONT></FONT> agents, each acting alone, with full powers of substitution and resubstitution, for him or her and in his or her name, place
and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">said&nbsp;attorneys-in-fact&nbsp;and</FONT></FONT> agents, each acting alone, full power and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the premises, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">said&nbsp;attorneys-in-fact&nbsp;and</FONT></FONT> agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities indicated on August 4, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="51%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Title</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vincent D. Mattera, Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vincent D. Mattera, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief&nbsp;Executive Officer and Chairman of the Board<BR>(Principal Executive Officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mary Jane Raymond</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Mary Jane Raymond</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer and Treasurer<BR>(Principal&nbsp;Financial and Accounting Officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Francis J. Kramer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Francis J. Kramer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman Emeritus of the Board</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph J. Corasanti</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Joseph J. Corasanti</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Enrico Digirolamo</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Enrico Digirolamo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael L. Dryer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael L. Dryer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Patricia Hatter</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Patricia Hatter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="51%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Motley</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">David Motley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lisa Neal-Graves</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Lisa Neal-Graves</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen Pagliuca</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Stephen Pagliuca</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Shaker Sadasivam</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shaker Sadasivam</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen A. Skaggs</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Stephen A. Skaggs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sandeep S. Vij</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Sandeep S. Vij</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Howard H. Xia</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Howard H. Xia</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d388182dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g388182dssp1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 4, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375 Saxonburg Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania 16056 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as special counsel to <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (the &#147;Company&#148;), in
connection with the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#147;Registration Statement&#148;) to be filed by the Company with the Securities and Exchange Commission on the date hereof, for the registration
under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), relating to the offering and sale, from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, by the selling securityholders named
therein or such selling securityholders as may be named in one or more prospectus supplements relating thereto (collectively, the &#147;Selling Securityholders&#148;) of (i)&nbsp;up to 140,000 shares (the &#147;Preferred Shares) of the
Company&#146;s Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, no par value (the &#147;Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock&#148;), and (ii)&nbsp;an unspecified number of shares of the
Company&#146;s common stock, no par value (the &#147;Common Stock&#148;), issuable upon conversion of the Preferred Shares, including pursuant to an increase in stated value as a result of accrued dividends payable in kind on the Preferred Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Agreement and Plan of Merger (the &#147;Merger Agreement&#148;), dated as of March&nbsp;25, 2021, by and among the Company, Coherent,
Inc., a Delaware corporation (&#147;Coherent&#148;), and Watson Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#147;Merger Sub&#148;), on July&nbsp;1, 2022, Merger Sub merged with and into Coherent (the
&#147;Coherent Merger&#148;), with Coherent continuing as the surviving corporation in the Coherent Merger and a wholly owned subsidiary of the Company. In connection with the Merger Agreement, the Company entered into an Amended and Restated
Investment Agreement, dated as of March&nbsp;30, 2021 (the &#147;Investment Agreement&#148;), with BCPE Watson (DE) SPV, LP, an affiliate of Bain Capital Private Equity, LP (the &#147;Investor&#148;). Pursuant to the terms and conditions of the
Investment Agreement, on the closing date of the Coherent Merger, BCPE Watson (DE) BML, LP, a Delaware limited partnership (&#147;BML&#148;), became the beneficial owner of 75,000 newly issued shares of Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock and BCPE Watson (DE) ORML, LP, a Delaware limited partnership (together with BML and their respective successors and any respective affiliates thereof that become investor parties to the
Investor Agreement, the &#147;Borrowers&#148;) became the beneficial owner of 65,000 newly issued shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock. Each of the Borrowers has signed an agreement for the applicable Back
Leverage (as defined in the Investment Agreement), which provides for, among other things, a pledge of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">K&amp;L GATES LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">K&amp;L GATES CENTER&nbsp;&nbsp;&nbsp;&nbsp;210 SIXTH AVENUE&nbsp;&nbsp;&nbsp;&nbsp;PITTSBURGH&nbsp;&nbsp;&nbsp;&nbsp;PA 15222-2613 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">T +1 412 355 6500 F +1 412 355 6501 klgates.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 4, 2022 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable Borrower&#146;s Preferred Shares to certain lenders party to the applicable Back Leverage (the relevant &#147;Lenders&#148;) in order to secure such Back Leverage. Following a
foreclosure by the relevant Lenders of the pledged Preferred Shares in connection with the applicable Back Leverage, the Selling Securityholders may pursuant to such Back Leverage offer and sell Preferred Shares and/or shares of Common Stock that
may be issued upon conversion of the Preferred Shares in amounts, at prices and on terms that will be determined at the time of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to
the terms and conditions of the Investment Agreement, the Company and the Investor entered into a registration rights agreement pursuant to which the Investor has certain customary registration rights with respect to the Preferred Shares
beneficially owned by the Borrowers and the shares of Common Stock issuable upon conversion thereof (the &#147;Registration Rights Agreement&#148;). The Company is registering the resale of the Preferred Shares and the shares of Common Stock
issuable upon conversion thereof pursuant to the terms of the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have requested our opinions as to the matters set forth
below in connection with the Registration Statement. For purposes of rendering those opinions, we have examined copies of the following documents: (i)&nbsp;the Company&#146;s Amended and Restated Articles of Incorporation, including the Statement
with Respect to Shares relating to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, dated March&nbsp;30, 2021 and filed by the Company with the Pennsylvania Department of State Corporation Bureau on March&nbsp;30, 2021 (the
&#147;Statement&#148;); (ii) the Company&#146;s Amended and Restated Bylaws, as amended and restated effective November&nbsp;19, 2021; (iii) the resolutions of the Board of Directors of the Company relating to (a)&nbsp;the Investment Agreement and
the Registration Rights Agreement, (b)&nbsp;the issuance of the Preferred Shares and the shares of Common Stock issuable upon conversion thereof, and (c)&nbsp;the filing of the Registration Statement; (iv)&nbsp;the Registration Statement; and
(v)&nbsp;such other corporate records of the Company, certificates of public officials and of officers of the Company and agreements and other documents as we have deemed necessary as a basis for the opinion expressed below. In rendering our opinion
expressed below, we have made the assumptions that are customary in opinion letters of this kind. We have not verified any of those assumptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based
upon and subject to the foregoing and the additional qualifications and other matters set forth below, we are of the opinion that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The
Preferred Shares have been duly authorized and are validly issued, fully paid, and nonassessable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The shares of Common Stock into which
the Preferred Shares will be convertible have been duly authorized, and, when issued and delivered upon conversion of such Preferred Shares in accordance with the manner provided for in the Statement, such shares of Common Stock will be validly
issued, fully paid, and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinions expressed in this opinion letter are limited to the Business Corporation Law of the Commonwealth of
Pennsylvania. The foregoing opinions are rendered as of the date of this opinion letter. We assume no obligation to update or supplement any of such opinions in order to reflect any changes of law or fact that may occur. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 4, 2022 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are furnishing this opinion letter to you solely in connection with the Registration Statement. You may
not rely on this opinion letter in any other connection, and it may not be furnished to or relied upon by any other person for any purpose, without our specific prior written consent. We hereby consent to the filing of this opinion letter as Exhibit
5.1 to the Registration Statement and to the use of our name under the heading &#147;Legal Matters&#148; contained in the prospectus included in the Registration Statement. In giving our consent, we do not thereby admit that we are in the category
of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yours truly,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ K&amp;L Gates LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d388182dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; in this Registration Statement (Form
<FONT STYLE="white-space:nowrap">S-3)</FONT> and related Prospectus of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated for the registration of its Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock and common
stock and to the incorporation by reference therein of our reports dated August&nbsp;20, 2021, with respect to the consolidated financial statements and schedule of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries, and the
effectiveness of internal control over financial reporting of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries, included in its Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended
June&nbsp;30, 2021, filed with the Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">/s/ Ernst&nbsp;&amp; Young LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pittsburgh, Pennsylvania </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 3, 2022 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>d388182dex233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.3 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the incorporation by reference in this Registration Statement of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> of our reports dated November&nbsp;29, 2021, relating to the consolidated financial statements of Coherent, Inc. and the effectiveness of Coherent, Inc.&#146;s internal control over financial reporting appearing
in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of Coherent, Inc. for the year ended October&nbsp;2, 2021. We also consent to the reference to us under the heading &#147;Experts&#148; in such Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ DELOITTE&nbsp;&amp; TOUCHE LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Jose, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;3, 2022 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>d388182dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Table </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 1: Newly Registered Securities </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;Security&nbsp;Type&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Security&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Class&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Title&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Fee&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Calculation&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Rule&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Amount&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Registered&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Proposed&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Maximum&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Offering&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Price Per &nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Unit&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Maximum&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Aggregate&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Offering&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Price&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Fee&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Rate&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Amount&nbsp;of&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Registration&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;Fee (2)&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8pt">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Preferred Stock, no par value</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">456(b)&nbsp;and&nbsp;457(r)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$0</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8pt">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">Common Stock, no par value</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">456(b) and 457(r)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$0</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" COLSPAN="7" ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8pt">Total Offering Amounts</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$0</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" COLSPAN="7" ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8pt">Total Fee Offsets</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" COLSPAN="7" ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8pt">Net Fee Due</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$0</TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">An unspecified number of shares of the registrant&#146;s Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock, no par value per share (&#147;Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock&#148;), is being registered as may from time to time be offered at unspecified prices and, in addition, an
unspecified number of shares of the registrant&#146;s common stock, no par value per share, is being registered as may be issued from time to time upon the conversion of any shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible
Preferred Stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, the registrant is
deferring payment of the entire registration fee. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g388182dssp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g388182dssp1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M_P#)_P#[0/\ AX9_U2'_ ,O_ /\ P*H_L[_I]_Y)_P#;!_:O_3C_ ,G_ /M
M_P"'AG_5(?\ R_\ _P# JC^SO^GW_DG_ -L']J_]./\ R?\ ^T#_ (>&?]4A
M_P#+_P#_ ,"J/[._Z??^2?\ VP?VK_TX_P#)_P#[0/\ AX9_U2'_ ,O_ /\
MP*H_L[_I]_Y)_P#;!_:O_3C_ ,G_ /M _P"'AG_5(?\ R_\ _P# JC^SO^GW
M_DG_ -L']J_]./\ R?\ ^T#_ (>&?]4A_P#+_P#_ ,"J/[._Z??^2?\ VP?V
MK_TX_P#)_P#[0/\ AX9_U2'_ ,O_ /\ P*H_L[_I]_Y)_P#;!_:O_3C_ ,G_
M /M _P"'AG_5(?\ R_\ _P# JC^SO^GW_DG_ -L']J_]./\ R?\ ^T#_ (>&
M?]4A_P#+_P#_ ,"J/[._Z??^2?\ VP?VK_TX_P#)_P#[0/\ AX9_U2'_ ,O_
M /\ P*H_L[_I]_Y)_P#;!_:O_3C_ ,G_ /M _P"'AG_5(?\ R_\ _P# JC^S
MO^GW_DG_ -L']J_]./\ R?\ ^T#_ (>&?]4A_P#+_P#_ ,"J/[._Z??^2?\
MVP?VK_TX_P#)_P#[0/\ AX9_U2'_ ,O_ /\ P*H_L[_I]_Y)_P#;!_:O_3C_
M ,G_ /M _P"'AG_5(?\ R_\ _P# JC^SO^GW_DG_ -L']J_]./\ R?\ ^T#_
M (>&?]4A_P#+_P#_ ,"J/[._Z??^2?\ VP?VK_TX_P#)_P#[0/\ AX9_U2'_
M ,O_ /\ P*H_L[_I]_Y)_P#;!_:O_3C_ ,G_ /M _P"'AG_5(?\ R_\ _P#
MJC^SO^GW_DG_ -L']J_]./\ R?\ ^T#_ (>&?]4A_P#+_P#_ ,"J/[._Z??^
M2?\ VP?VK_TX_P#)_P#[0^E/V>?VAO\ A?/_  E__%(?\(I_PBO]@?\ ,?\
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M?_U*/&-:Y?\ P9?XW_Z3$QS/^/#_ *]K_P!*F?$-=QYP4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 ?I1_P3S_ .:O?]R!_P"[K7F9C_RY_P"W
M_P#VT]?*O^7_ /VY_P"WGFO[?'_)8?#?_9-='_\ 4H\8UKE_\&7^-_\ I,3'
M,_X\/^O:_P#2IGQ#7<><% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M?]R!_P"[K7F9C_RY_P"W_P#VT]?*O^7_ /VY_P"WGFO[?'_)8?#?_9-='_\
M4H\8UKE_\&7^-_\ I,3',_X\/^O:_P#2IGQ#7<><% !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % 'Z4?\$\_^:O?]R!_[NM>9F/_ "Y_[?\ _;3U
M\J_Y?_\ ;G_MYYK^WQ_R6'PW_P!DUT?_ -2CQC6N7_P9?XW_ .DQ,<S_ (\/
M^O:_]*F?$-=QYP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?I
M1_P3S_YJ]_W('_NZUYF8_P#+G_M__P!M/7RK_E__ -N?^WGFO[?'_)8?#?\
MV371_P#U*/&-:Y?_  9?XW_Z3$QS/^/#_KVO_2IGQ#7<><% !0 4 % !0 4
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MF111PQ+')*7,L"L@CM%<))(5,TI^SG^Z?-%+;S_/;Y&=6'-']XN7_);'RO\
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M\D'_  R#^T3_ -$\_P#+L\#?_--1]<PW_/S_ ,EE_P#(A]0Q?_/K_P FA_\
M)!_PR#^T3_T3S_R[/ W_ ,TU'US#?\_/_)9?_(A]0Q?_ #Z_\FA_\D'_  R#
M^T3_ -$\_P#+L\#?_--1]<PW_/S_ ,EE_P#(A]0Q?_/K_P FA_\ )!_PR#^T
M3_T3S_R[/ W_ ,TU'US#?\_/_)9?_(A]0Q?_ #Z_\FA_\D'_  R#^T3_ -$\
M_P#+L\#?_--1]<PW_/S_ ,EE_P#(A]0Q?_/K_P FA_\ )!_PR#^T3_T3S_R[
M/ W_ ,TU'US#?\_/_)9?_(A]0Q?_ #Z_\FA_\D'_  R#^T3_ -$\_P#+L\#?
M_--1]<PW_/S_ ,EE_P#(A]0Q?_/K_P FA_\ )!_PR#^T3_T3S_R[/ W_ ,TU
M'US#?\_/_)9?_(A]0Q?_ #Z_\FA_\D'_  R#^T3_ -$\_P#+L\#?_--1]<PW
M_/S_ ,EE_P#(A]0Q?_/K_P FA_\ )!_PR#^T3_T3S_R[/ W_ ,TU'US#?\_/
M_)9?_(A]0Q?_ #Z_\FA_\D'_  R#^T3_ -$\_P#+L\#?_--1]<PW_/S_ ,EE
M_P#(A]0Q?_/K_P FA_\ )!_PR#^T3_T3S_R[/ W_ ,TU'US#?\_/_)9?_(A]
M0Q?_ #Z_\FA_\D'_  R#^T3_ -$\_P#+L\#?_--1]<PW_/S_ ,EE_P#(A]0Q
M?_/K_P FA_\ )!_PR#^T3_T3S_R[/ W_ ,TU'US#?\_/_)9?_(A]0Q?_ #Z_
M\FA_\D?;W[&WP@^(GPH_X6/_ ,)]X>_L'^WO^$0_LG_B;:'JGVK^R_\ A*/M
MW_(%U.[\CRO[1L_]=Y>[SODW;'V\&-K4ZOLO9RYN7FOHUORVW2[,]'+Z%6A[
M7VL.7FY;:I[<U]F]KH^WJX3T0H * "@ H * "@ H * "@ H * "@ H * "@
-H * "@ H * "@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g388182g82q21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g388182g82q21.jpg
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MAD(Z>EFP-E7AV9P=BHJW.LBW42_9U/AU-D8\YE'V1<%U 4W 1'!$A0LVS N
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M_'(.)LNE[Q:?%3^'^:8OV<R_+):98.L'\(_N3$''^SO>-<]=<3'MP7U]YO\
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5_P"; P_1@V(?U,/_ +DNO_/,?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
